###begin article-title 0
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn3">S&#8414;</xref>
MacB ABC Transporter Is a Dimer Whose ATPase Activity and Macrolide-binding Capacity Are Regulated by the Membrane Fusion Protein MacA*Sâƒž
###end article-title 0
###begin p 1
These authors contributed equally to this work.
###end p 1
###begin p 2
###xml 55 69 55 69 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">European Union</grant-sponsor>
Supported in part by a Marie Curie fellowship from the European Union.
###end p 2
###begin p 3
###xml 17 71 17 71 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Biotechnology and Biological Sciences Research Council</grant-sponsor>
Supported by the Biotechnology and Biological Sciences Research Council.
###end p 3
###begin p 4
###xml 29 43 29 43 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Wellcome Trust</grant-sponsor>
Supported by grants from the Wellcome Trust.
###end p 4
###begin p 5
###xml 103 135 103 135 <email xmlns:xlink="http://www.w3.org/1999/xlink">m.i.borges-walmsley@durham.ac.uk</email>
 To whom correspondence may be addressed. Tel.: 44-191-334-0465 or 0467; Fax: 44-191-334-0468; E-mail: m.i.borges-walmsley@durham.ac.uk.
###end p 5
###begin p 6
###xml 170 195 170 195 <email xmlns:xlink="http://www.w3.org/1999/xlink">a.r.walmsley@durham.ac.uk</email>
 To whom correspondence may be addressed: School of Biological and Biomedical Sciences, Durham University, South Road, Durham DH1 3LE, UK. Tel.: 44-191-334-9165; E-mail: a.r.walmsley@durham.ac.uk.
###end p 6
###begin p 7
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 7
###begin p 8
 applies to Author Choice Articles
###end p 8
###begin p 9
###xml 426 442 426 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 426 442 <span type="species:ncbi:562">Escherichia coli</span>
Gram-negative bacteria utilize specialized machinery to translocate drugs and protein toxins across the inner and outer membranes, consisting of a tripartite complex composed of an inner membrane secondary or primary active transporter (IMP), a periplasmic membrane fusion protein, and an outer membrane channel. We have investigated the assembly and function of the MacAB/TolC system that confers resistance to macrolides in Escherichia coli. The membrane fusion protein MacA not only stabilizes the tripartite assembly by interacting with both the inner membrane protein MacB and the outer membrane protein TolC, but also has a role in regulating the function of MacB, apparently increasing its affinity for both erythromycin and ATP. Analysis of the kinetic behavior of ATP hydrolysis indicated that MacA promotes and stabilizes the ATP-binding form of the MacB transporter. For the first time, we have established unambiguously the dimeric nature of a noncanonic ABC transporter, MacB that has an N-terminal nucleotide binding domain, by means of nondissociating mass spectrometry, analytical ultracentrifugation, and atomic force microscopy. Structural studies of ABC transporters indicate that ATP is bound between a pair of nucleotide binding domains to stabilize a conformation in which the substrate-binding site is outward-facing. Consequently, our data suggest that in the presence of ATP the same conformation of MacB is promoted and stabilized by MacA. Thus, MacA would facilitate the delivery of drugs by MacB to TolC by enhancing the binding of drugs to it and inducing a conformation of MacB that is primed and competent for binding TolC. Our structural studies are an important first step in understanding how the tripartite complex is assembled.
###end p 9
###begin p 10
###xml 43 57 43 57 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Wellcome Trust</grant-sponsor>
###xml 215 228 215 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
This work was supported by grants from the Wellcome Trust (Durham group). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 10
###begin p 11
The on-line version of this article (available at ) contains supplemental Methods, Figs. 1 and 2, Tables 1 and 2, and additional references.
###end p 11
###begin p 12
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 12
###begin p 13
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 302 303 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn8">7</xref>
###xml 540 541 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 627 628 623 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 681 682 677 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 794 795 790 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 902 903 898 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 905 906 901 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 972 973 968 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 1039 1040 1031 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
Gram-negative bacteria utilize transport systems composed of a tripartite assembly of proteins that span both the inner and outer membranes to pump cytotoxic compounds, such as antibiotics (1), and protein toxins (2), such as alpha-hemolysin, from the cell. These assemblies are composed of inner (IMP)7 and outer (OMP) membrane proteins that are connected by a periplasmic membrane fusion protein (MFP), which is anchored to the inner membrane. The systems responsible for toxin extrusion invariably utilize an ABC transporter as the IMP (2), whereas those involved in antibiotic extrusion largely utilize proton antiporters (1), but there are some that utilize ABC transporters (3). The same OMP can be utilized for both drug and toxin extrusion; for example, TolC functions with antibiotic H+ antiporters, such as AcrB that belongs to the regulation nodulation cell division family of transporters (4, 5), with ABC transporters, such as the macrolide transporter MacB (3), and with HlyB that extrudes the protein toxin alpha-hemolysin (2).
###end p 13
###begin p 14
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 870 872 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 1003 1005 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 1235 1236 1221 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 1321 1323 1303 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1358 1360 1337 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 1400 1401 1379 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 1403 1404 1382 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
Although the structure of an assembled tripartite complex has not yet been determined, the structures of a few individual components have been elucidated. Most significantly, the structure of the RND transporter AcrB (6, 7) and of its cognate MFP, AcrA (8), and OMP, TolC (9), have been determined. Both AcrB and TolC are organized as homotrimers. The AcrB trimer has a periplasmic headpiece formed by the loops between helices 1 and 2 and helices 7 and 8. The headpiece has a funnel-shaped internal cavity that is connected by a pore to a large central cavity formed between the periplasmic and membrane domains. The trimeric TolC forms a cylindrical channel with a structure that is arranged into two major domains as follows: a beta-barrel in the outer membrane and a periplasmic alpha-helical barrel. It has been proposed, and is supported by cross-linking studies (10), that the six hairpins from the upper headpiece of the AcrB trimer contact the tips of the six helical pairs of the TolC trimer (11) to form a continuous path across the periplasmic space. The structure of AcrA revealed an elongated monomer that is composed of three subdomains as follows: a beta-barrel, a lipoyl domain, and a 58-A-long alpha-helical hairpin (8). AcrA has been reported to interact with both TolC, via the alpha-helical hairpin (12), and AcrB, via the beta-domains (13), to stabilize the tripartite complex (4, 5).
###end p 14
###begin p 15
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 701 702 701 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 946 948 946 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 949 951 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 1064 1066 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 1198 1214 1198 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 1473 1475 1473 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 1198 1214 <span type="species:ncbi:562">Escherichia coli</span>
Several lines of evidence suggest that assembly of the tripartite complex is a dynamic process that induces conformational changes in the protein components. The structures of a number of OMPs indicate that the channel is closed at one or both sides, requiring conformational changes to allow passage of the substrate (11-14). Several studies support the hypothesis that a small number of key interactions between adjacent coiled-coils of the OMP are broken to allow the inner coils to untwist and realign with the outer coils, thereby opening the OMP entrance aperture (11, 15-17). The conformational flexibility of AcrA may enable realignment of the coiled-coil to stabilize the open state of TolC (8, 11, 15). Recently, the structures of a number of different conformations of AcrB have been determined that support a mechanistic model in which there is a functional rotation in the periplasmic domains driving transfer of drugs into the OMP (18-21). The conformational asymmetry in the IMP is also reflected in the asymmetry in the open state of the OMP TolC (11). Such conformational changes in AcrB could be transmitted to TolC via AcrA. Furthermore, studies of the RND transporter AcrD from Escherichia coli, whose typical substrates, aminoglycosides, are not expected to diffuse spontaneously across the lipid bilayer, revealed that only when AcrD was reconstituted with AcrA was it able to take up aminoglycosides, implying that AcrA is needed to "activate" AcrD (22). Collectively, these findings suggest that the MFP supports conformational changes in both the IMP and OMP.
###end p 15
###begin p 16
###xml 153 160 153 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 499 500 499 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 888 890 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 1298 1319 1298 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 153 160 <span type="species:ncbi:562">E. coli</span>
###xml 1298 1319 <span type="species:ncbi:1280">Staphylococcus aureus</span>
We have sought to further investigate the assembly of the tripartite complex using the MacABTolC system responsible for the extrusion of macrolides from E. coli (3). To date this is the only tripartite pump for antibiotics that has been shown to utilize an ABC transporter, MacB, which has a novel architecture, consisting of a four-helix transmembrane domain, an N-terminal cytoplasmic nucleotide binding domain (NBD), and a large periplasmic domain formed by the loops connecting helices 1 and 2 (3, 23). The fact that the ATPase activity of the transporter can be monitored, using purified proteins, provides an additional tool for elucidating how its activity is modulated by assembly and disassembly of the tripartite complex. Indeed, recent studies, reported while this work was in progress, established that the MFP MacA modulates the steady-state ATPase activity of the IMP MacB (24). Our studies have confirmed these findings and, by undertaking pre-steady-state analysis of the kinetics, extended them by identifying how MacA modulates the ATPase mechanism of MacB. In addition, we have established that MacA also increases the capacity of MacB for binding erythromycin. This behavior provides a rationale for the retention of MacA by related systems from Gram-positive bacteria, such as Staphylococcus aureus, which lack an outer membrane and OMP (supplemental Fig. 1). Such analyses will not only have a bearing on understanding the function of tripartite drug-pumps but also of related toxin transporters.
###end p 16
###begin title 17
EXPERIMENTAL PROCEDURES
###end title 17
###begin p 18
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Strains and Plasmids</italic>
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 25 32 <span type="species:ncbi:562">E. coli</span>
Strains and Plasmids-The E. coli strains and plasmids used are described in supplemental Table 1, and the primers used for construction of plasmid vectors are described in supplemental Table 2.
###end p 18
###begin p 19
###xml 0 39 0 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Protein Overexpression and Purification</italic>
###xml 139 146 139 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 139 146 <span type="species:ncbi:562">E. coli</span>
Protein Overexpression and Purification-All the proteins used in this study were purified as fusion proteins with a six-histidine tag from E. coli overexpressing strains according to the protocols given in the supplemental material.
###end p 19
###begin p 20
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pulldown Assays</italic>
###xml 332 334 332 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 577 578 577 578 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 747 748 747 748 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Pulldown Assays-For pulldown assays, proteins were overexpressed with a C-terminal S-tag for use with the cognate protein that was His-tagged. Membrane pellets, dissolved in detergent, or cell supernatant containing the S-tagged prey protein were mixed with 2 mg of purified His-tagged bait-protein. The mixture was loaded onto a Ni2+-charged Hitrap chelating column (GE Healthcare), so that the bait-protein could be immobilized on the column along with the prey-protein if they interact. The column was then washed with 15-20 column volumes of Tris buffer containing 75-100 mm imidazole and Triton X-100 (0.2% (v/v)) to eliminate any false-positive results because of nonspecific interactions. The bait-prey protein complex was eluted with 500 mm imidazole Tris buffer, containing Triton X-100 (0.2% (v/v)), and SDS-PAGE was used to visualize the bait- and prey-proteins. A Western blot was performed with anti-S-tag antibodies to confirm the presence of the S-tagged prey-protein.
###end p 20
###begin p 21
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Growth Curve Analyses</italic>
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 160 161 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 161 164 155 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 188 189 182 183 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 212 213 203 204 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 622 623 611 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 623 626 612 615 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 22 29 <span type="species:ncbi:562">E. coli</span>
Growth Curve Analyses-E. coli cells, of strain KAM3(DE3), harboring plasmids were grown at 37 degreesC, with shaking at 200 rpm, until the cell density gave an A600 of 0.5, when 0.05-0.1 mm isopropyl 1-thio-beta-d-galactopyranoside was added to the cells. The cells were grown for a further 3 h, when the cells were diluted with 2x YT media containing 100 mug/ml erythromycin, and the growth curve was recorded over the next 12 h. For experiments to measure the loss in growth because of erythromycin, cells were grown for 3 h in the absence and presence of 50 mug/ml erythromycin, and the growth loss is the ratio of the A600 values.
###end p 21
###begin p 22
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Analytical Ultracentrifugation</italic>
###xml 228 229 227 228 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 249 250 248 249 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 334 335 330 331 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 563 564 558 559 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 668 670 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
Analytical Ultracentrifugation-Sedimentation equilibrium measurements were performed using a Beckman Optima XL-A analytical ultracentrifuge equipped with both absorbance and interference optics. 100 mul of MacB in buffer 1 (20 mm Tris, pH 8.0, 150 mm NaCl, 1% w/v glycerol, and 0.006% (w/v) betaDDM) supplemented with 10, 25, or 50% D2O was placed in the sample compartment of a Epon double-sector centerpiece, and 110 mul of buffer 1 was placed in the reference compartment. The final protein concentrations used in the runs were between 0.5 and 1.0 mg/ml. The D2O was used to match the density of the solvent to the density of the detergent as described previously (25) The samples were centrifuged at 283 K (10 degreesC) and 10,000, 15,000, and 25,000 rpm using an An60-Ti rotor. Scans were acquired using the absorbance optical system 15 h after the start of the experiment and in 1-h intervals until equilibrium was attained. Sedimentation velocity measurements were performed using the same hardware at 55,000 rpm at 10 degreesC in buffer 1. The details of the data analysis are given as supplemental material.
###end p 22
###begin p 23
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 48 9 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MacA interacts with both MacB and TolC.</bold>
###xml 48 50 48 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 152 158 152 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 167 173 167 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 2</italic>
###xml 186 192 186 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 289 291 289 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 371 375 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 633 635 629 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 662 665 658 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1st</italic>
###xml 670 680 666 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2nd lanes,</italic>
###xml 736 744 732 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1st lane</italic>
###xml 831 839 827 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2nd lane</italic>
###xml 842 845 838 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3rd</italic>
###xml 849 860 845 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">11th lanes,</italic>
###xml 1004 1006 1000 1002 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1130 1133 1126 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">7th</italic>
###xml 1137 1146 1133 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">9th lanes</italic>
###xml 1167 1175 1163 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">9th lane</italic>
###xml 1183 1184 1179 1180 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1201 1209 1197 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8th lane</italic>
###xml 1225 1226 1221 1222 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1246 1254 1242 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">7th lane</italic>
###xml 1501 1503 1497 1499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1520 1523 1516 1519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3rd</italic>
###xml 1527 1536 1523 1532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5th lanes</italic>
###xml 1561 1569 1557 1565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5th lane</italic>
###xml 1577 1578 1573 1574 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1595 1603 1591 1599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4th lane</italic>
###xml 1619 1620 1615 1616 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1640 1648 1636 1644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3rd lane</italic>
###xml 1730 1738 1726 1734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5th lane</italic>
###xml 1973 1982 1969 1978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10th lane</italic>
###xml 1985 1987 1981 1983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 2041 2050 2037 2046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1-8</italic>
###xml 2141 2148 2137 2144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 2149 2151 2145 2147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-8</italic>
###xml 2265 2267 2261 2263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 2284 2291 2280 2287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 2296 2297 2292 2293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 2453 2459 2449 2455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 2</italic>
###xml 2464 2465 2460 2461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 2510 2511 2506 2507 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2523 2530 2519 2526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3</italic>
###xml 2535 2536 2531 2532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 2560 2561 2556 2557 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2573 2580 2569 2576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 4</italic>
###xml 2585 2586 2581 2582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 2673 2680 2669 2676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 6</italic>
###xml 2685 2686 2681 2682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 2762 2763 2758 2759 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2765 2772 2761 2768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 7</italic>
###xml 2777 2778 2773 2774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">7</italic>
###xml 2790 2791 2786 2787 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2793 2800 2789 2796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 8</italic>
###xml 2805 2806 2801 2802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8</italic>
###xml 2820 2826 2816 2822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 2832 2833 2828 2829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8</italic>
###xml 2952 2954 2948 2950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D,</italic>
###xml 3008 3017 3004 3013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1-4</italic>
###xml 3108 3115 3104 3111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 3116 3118 3112 3114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-4</italic>
###xml 3232 3234 3228 3230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 3251 3258 3247 3254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 3263 3264 3259 3260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 3387 3393 3383 3389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 3398 3399 3394 3395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 3434 3435 3430 3431 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3447 3454 3443 3450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 4</italic>
###xml 3459 3460 3455 3456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 3505 3506 3501 3502 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3518 3525 3514 3521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 5</italic>
###xml 3530 3531 3526 3527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 3622 3628 3618 3624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 3767 3768 3763 3764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">o</italic>
###xml 3794 3796 3790 3792 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 3834 3840 3830 3836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6</italic>
###xml 3852 3853 3848 3849 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3870 3876 3866 3872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 7</italic>
###xml 3892 3893 3888 3889 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3913 3919 3909 3915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 8</italic>
###xml 4001 4007 3997 4003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6</italic>
###xml 4082 4083 4078 4079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 4083 4084 4079 4080 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 4103 4113 4099 4109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 2. E,</italic>
###xml 4214 4220 4210 4216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 4250 4252 4246 4248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 4269 4275 4265 4271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 4381 4387 4373 4379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 2</italic>
###xml 4497 4503 4489 4495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 4565 4566 4557 4558 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 4578 4584 4570 4576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 4626 4627 4618 4619 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 4639 4645 4631 4637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 4740 4741 4732 4733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 4742 4744 4734 4736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-5</italic>
###xml 4861 4862 4853 4854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 4862 4863 4854 4855 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 4944 4950 4936 4942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 5000 5006 4992 4998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 5124 5126 5112 5114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 5164 5170 5152 5158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 7</italic>
###xml 5211 5212 5199 5200 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 5224 5231 5212 5219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 8</italic>
###xml 5236 5237 5224 5225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">9</italic>
###xml 5267 5268 5255 5256 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 5288 5295 5276 5283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 10</italic>
###xml 5392 5398 5380 5386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 7</italic>
###xml 5404 5405 5392 5393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8</italic>
###xml 5635 5636 5619 5620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 5636 5637 5620 5621 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 5656 5663 5640 5647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6.</italic>
###xml 9 5663 9 5647 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="24"><bold>MacA interacts with both MacB and TolC.</bold><italic>A,</italic> overexpression and purification of MacA, MacB, and TolC. An SDS-polyacrylamide gel of purified MacB (<italic>lane 1</italic>), MacA (<italic>lane 2</italic>), and TolC (<italic>lane 3</italic>) is shown. The purified His-tagged MacB and TolC proteins were used as bait, immobilized on a Ni<sup>2+</sup>-agarose column, over which a slurry of either detergent-solubilized membranes (<italic>e.g.</italic> from strains overexpressing S-tagged MacA or TolC) or soluble proteins (<italic>e.g.</italic> from strains overexpressing S-tagged &#916;20MacA) was passed to test whether the cognate proteins from the tripartite pump could be pulled out of this complex mixture of proteins. <italic>B,</italic> pulldown of MacA by MacB. <italic>1st</italic> and <italic>2nd lanes,</italic> SDS-polyacrylamide gel of immobilized His-tagged MacB (<italic>1st lane</italic>) and the detergent-solubilized membranes from cells overexpressing the S-tagged MacA (<italic>2nd lane</italic>). <italic>3rd</italic> to <italic>11th lanes,</italic> Western blot using antibodies to the S-tag (1:5000 dilution) on MacA. The pulldown assay was performed with His-tagged MacB immobilized on a Ni<sup>2+</sup>-agarose column, over which a slurry of detergent-solubilized membranes from cells overexpressing S-tagged MacA was passed (<italic>7th</italic> to <italic>9th lanes</italic>). The flow-through (<italic>9th lane</italic>), 100 m<sc>m</sc> imidazole wash (<italic>8th lane</italic>), and the 500 m<sc>m</sc> imidazole elution (<italic>7th lane</italic>) were tested for the presence of MacA, which was now also detected in the elution fraction, indicating that it was bound to MacB. A negative control experiment was performed in the absence of immobilized MacB in which MacA was passed through a Ni<sup>2+</sup>-agarose column (<italic>3rd</italic> to <italic>5th lanes</italic>), and the flow-through (<italic>5th lane</italic>), 100 m<sc>m</sc> imidazole wash (<italic>4th lane</italic>), and the 500 m<sc>m</sc> imidazole elution (<italic>3rd lane</italic>) were tested for the presence of MacA, which was only found in the flow-through (<italic>5th lane</italic>), establishing that S-tagged MacA does not bind to the column. These results indicate that MacB can pull MacA from a complex mixture of membrane proteins. Purified His-tagged MacB did not cross-react with the antibodies to the S-tag (<italic>10th lane</italic>). <italic>C,</italic> pulldown of MacA by TolC. An SDS-polyacrylamide gel (<italic>lanes 1-8</italic>) for the pulldown of S-tagged MacA by His-tagged TolC and the corresponding Western blot (<italic>lanes 1</italic>&#8242;<italic>-8</italic>&#8242;) probed with antibodies (1:5000 dilution) to the S-tag on MacA. Purified His-tagged TolC was immobilized on a Ni<sup>2+</sup>-agarose column (<italic>lanes 1</italic> and <italic>1</italic>&#8242;); a slurry of detergent-solubilized membranes from cells overexpressing S-tagged MacA was passed through the column and the proteins in the flow-through (<italic>lane 2</italic> and <italic>2</italic>&#8242;), released by washing the column with 100 m<sc>m</sc> imidazole (<italic>lanes 3</italic> and <italic>3</italic>&#8242;) and eluted with 500 m<sc>m</sc> imidazole (<italic>lanes 4</italic> and <italic>4</italic>&#8242;), were detected. As a negative control, S-tagged MacA was passed through the column (<italic>lanes 6</italic> and <italic>6</italic>&#8242;), in the absence of immobilized TolC, and the column was washed with 100 m<sc>m</sc> (<italic>lanes 7</italic> and <italic>7</italic>&#8242;) and 500 m<sc>m</sc> (<italic>lanes 8</italic> and <italic>8</italic>&#8242;). Comparing <italic>lane 4</italic>&#8242; and <italic>8</italic>&#8242; demonstrates that MacA is only bound to the column in the presence of TolC, indicative of its interaction with TolC. <italic>D,</italic> pulldown of TolC by MacB. An SDS-polyacrylamide gel (<italic>lanes 1-4</italic>) for the pulldown of S-tagged TolC by His-tagged MacB and the corresponding Western blot (<italic>lanes 1</italic>&#8242;<italic>-4</italic>&#8242;) probed with antibodies (1:5000 dilution) to the S-tag on TolC. Purified His-tagged MacB was immobilized on a Ni<sup>2+</sup>-agarose column (<italic>lanes 1</italic> and <italic>1</italic>&#8242;), and a slurry of detergent-solubilized membranes from cells overexpressing S-tagged TolC was passed through the column (<italic>lane 3</italic> and <italic>3</italic>&#8242;), which was then washed with 75 m<sc>m</sc> imidazole (<italic>lanes 4</italic> and <italic>4</italic>&#8242;), and bound proteins were eluted with 500 m<sc>m</sc> imidazole (<italic>lanes 5</italic> and <italic>5</italic>&#8242;). A weak band, which was not present in the absence of immobilized MacB, was apparent in <italic>lane 5</italic>&#8242;, indicative of a weak interaction between MacB and TolC. A control experiment was performed in the absence of immobilized MacB in which T<italic>o</italic>lC was passed through a Ni<sup>2+</sup>-agarose column and the flow-through (<italic>lane 6</italic>), the 100 m<sc>m</sc> imidazole wash (<italic>lane 7</italic>), and the 500 m<sc>m</sc> imidazole elution (<italic>lane 8</italic>) were tested for the presence of TolC, which was only found in the flow-through (<italic>lane 6</italic>&#8242;), establishing that S-tagged TolC does not bind to the column. A protein <italic>M</italic><sub>r</sub> marker was run in <italic>lane 2. E,</italic> pulldown of N-terminal truncated MacA by MacB. An SDS-polyacrylamide gel shows the His-tagged MacB (<italic>lane 1</italic>) that was immobilized on a Ni<sup>2+</sup>-agarose column (<italic>lane 1</italic>), a slurry of cytoplasmic proteins released by disruption of cells overexpressing S-tagged &#916;20-MacA (<italic>lane 2</italic>), which was passed through the column, over immobilized MacB, and the proteins in the flow-through detected (<italic>lane 3</italic>); the proteins were released by washing the column with 100 m<sc>m</sc> imidazole (<italic>lane 4</italic>); and the proteins were eluted with 500 m<sc>m</sc> imidazole (<italic>lane 5</italic>). A Western blot was performed on each of the corresponding protein fractions (indicated with <italic>1</italic>&#8242;<italic>-5</italic>&#8242;) using antibodies to the S-tag (1:5000 dilution) to detect S-tagged MacA. The elution of MacB yields an extra, low <italic>M</italic><sub>r</sub>, band on the SDS-polyacrylamide gel that corresponds to that expected for MacA (<italic>lane 5</italic>) and was identified as such by Western blotting (<italic>lane 5</italic>&#8242;). A control experiment was performed in the absence of immobilized MacB in which &#916;20MacA was passed through a Ni<sup>2+</sup>-agarose column and the flow-through (<italic>lane 7</italic>), the first and second washes with 100 m<sc>m</sc> imidazole (<italic>lanes 8</italic> and <italic>9</italic>, respectively), and the 500 m<sc>m</sc> imidazole elution (<italic>lane 10</italic>) were tested for the presence of MacA, which was only found in the flow-through and first wash (<italic>lane 7</italic>&#8242; and <italic>8</italic>&#8242;, respectively), establishing that S-tagged MacA does not bind to the column. These results indicate that MacA does not require the N-terminal &#945;-helix, which anchors it to the inner membrane, to interact with MacB. A protein <italic>M</italic><sub>r</sub> marker was run in <italic>lane 6.</italic></p>
###xml 9 5663 9 5647 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="24"><bold>MacA interacts with both MacB and TolC.</bold><italic>A,</italic> overexpression and purification of MacA, MacB, and TolC. An SDS-polyacrylamide gel of purified MacB (<italic>lane 1</italic>), MacA (<italic>lane 2</italic>), and TolC (<italic>lane 3</italic>) is shown. The purified His-tagged MacB and TolC proteins were used as bait, immobilized on a Ni<sup>2+</sup>-agarose column, over which a slurry of either detergent-solubilized membranes (<italic>e.g.</italic> from strains overexpressing S-tagged MacA or TolC) or soluble proteins (<italic>e.g.</italic> from strains overexpressing S-tagged &#916;20MacA) was passed to test whether the cognate proteins from the tripartite pump could be pulled out of this complex mixture of proteins. <italic>B,</italic> pulldown of MacA by MacB. <italic>1st</italic> and <italic>2nd lanes,</italic> SDS-polyacrylamide gel of immobilized His-tagged MacB (<italic>1st lane</italic>) and the detergent-solubilized membranes from cells overexpressing the S-tagged MacA (<italic>2nd lane</italic>). <italic>3rd</italic> to <italic>11th lanes,</italic> Western blot using antibodies to the S-tag (1:5000 dilution) on MacA. The pulldown assay was performed with His-tagged MacB immobilized on a Ni<sup>2+</sup>-agarose column, over which a slurry of detergent-solubilized membranes from cells overexpressing S-tagged MacA was passed (<italic>7th</italic> to <italic>9th lanes</italic>). The flow-through (<italic>9th lane</italic>), 100 m<sc>m</sc> imidazole wash (<italic>8th lane</italic>), and the 500 m<sc>m</sc> imidazole elution (<italic>7th lane</italic>) were tested for the presence of MacA, which was now also detected in the elution fraction, indicating that it was bound to MacB. A negative control experiment was performed in the absence of immobilized MacB in which MacA was passed through a Ni<sup>2+</sup>-agarose column (<italic>3rd</italic> to <italic>5th lanes</italic>), and the flow-through (<italic>5th lane</italic>), 100 m<sc>m</sc> imidazole wash (<italic>4th lane</italic>), and the 500 m<sc>m</sc> imidazole elution (<italic>3rd lane</italic>) were tested for the presence of MacA, which was only found in the flow-through (<italic>5th lane</italic>), establishing that S-tagged MacA does not bind to the column. These results indicate that MacB can pull MacA from a complex mixture of membrane proteins. Purified His-tagged MacB did not cross-react with the antibodies to the S-tag (<italic>10th lane</italic>). <italic>C,</italic> pulldown of MacA by TolC. An SDS-polyacrylamide gel (<italic>lanes 1-8</italic>) for the pulldown of S-tagged MacA by His-tagged TolC and the corresponding Western blot (<italic>lanes 1</italic>&#8242;<italic>-8</italic>&#8242;) probed with antibodies (1:5000 dilution) to the S-tag on MacA. Purified His-tagged TolC was immobilized on a Ni<sup>2+</sup>-agarose column (<italic>lanes 1</italic> and <italic>1</italic>&#8242;); a slurry of detergent-solubilized membranes from cells overexpressing S-tagged MacA was passed through the column and the proteins in the flow-through (<italic>lane 2</italic> and <italic>2</italic>&#8242;), released by washing the column with 100 m<sc>m</sc> imidazole (<italic>lanes 3</italic> and <italic>3</italic>&#8242;) and eluted with 500 m<sc>m</sc> imidazole (<italic>lanes 4</italic> and <italic>4</italic>&#8242;), were detected. As a negative control, S-tagged MacA was passed through the column (<italic>lanes 6</italic> and <italic>6</italic>&#8242;), in the absence of immobilized TolC, and the column was washed with 100 m<sc>m</sc> (<italic>lanes 7</italic> and <italic>7</italic>&#8242;) and 500 m<sc>m</sc> (<italic>lanes 8</italic> and <italic>8</italic>&#8242;). Comparing <italic>lane 4</italic>&#8242; and <italic>8</italic>&#8242; demonstrates that MacA is only bound to the column in the presence of TolC, indicative of its interaction with TolC. <italic>D,</italic> pulldown of TolC by MacB. An SDS-polyacrylamide gel (<italic>lanes 1-4</italic>) for the pulldown of S-tagged TolC by His-tagged MacB and the corresponding Western blot (<italic>lanes 1</italic>&#8242;<italic>-4</italic>&#8242;) probed with antibodies (1:5000 dilution) to the S-tag on TolC. Purified His-tagged MacB was immobilized on a Ni<sup>2+</sup>-agarose column (<italic>lanes 1</italic> and <italic>1</italic>&#8242;), and a slurry of detergent-solubilized membranes from cells overexpressing S-tagged TolC was passed through the column (<italic>lane 3</italic> and <italic>3</italic>&#8242;), which was then washed with 75 m<sc>m</sc> imidazole (<italic>lanes 4</italic> and <italic>4</italic>&#8242;), and bound proteins were eluted with 500 m<sc>m</sc> imidazole (<italic>lanes 5</italic> and <italic>5</italic>&#8242;). A weak band, which was not present in the absence of immobilized MacB, was apparent in <italic>lane 5</italic>&#8242;, indicative of a weak interaction between MacB and TolC. A control experiment was performed in the absence of immobilized MacB in which T<italic>o</italic>lC was passed through a Ni<sup>2+</sup>-agarose column and the flow-through (<italic>lane 6</italic>), the 100 m<sc>m</sc> imidazole wash (<italic>lane 7</italic>), and the 500 m<sc>m</sc> imidazole elution (<italic>lane 8</italic>) were tested for the presence of TolC, which was only found in the flow-through (<italic>lane 6</italic>&#8242;), establishing that S-tagged TolC does not bind to the column. A protein <italic>M</italic><sub>r</sub> marker was run in <italic>lane 2. E,</italic> pulldown of N-terminal truncated MacA by MacB. An SDS-polyacrylamide gel shows the His-tagged MacB (<italic>lane 1</italic>) that was immobilized on a Ni<sup>2+</sup>-agarose column (<italic>lane 1</italic>), a slurry of cytoplasmic proteins released by disruption of cells overexpressing S-tagged &#916;20-MacA (<italic>lane 2</italic>), which was passed through the column, over immobilized MacB, and the proteins in the flow-through detected (<italic>lane 3</italic>); the proteins were released by washing the column with 100 m<sc>m</sc> imidazole (<italic>lane 4</italic>); and the proteins were eluted with 500 m<sc>m</sc> imidazole (<italic>lane 5</italic>). A Western blot was performed on each of the corresponding protein fractions (indicated with <italic>1</italic>&#8242;<italic>-5</italic>&#8242;) using antibodies to the S-tag (1:5000 dilution) to detect S-tagged MacA. The elution of MacB yields an extra, low <italic>M</italic><sub>r</sub>, band on the SDS-polyacrylamide gel that corresponds to that expected for MacA (<italic>lane 5</italic>) and was identified as such by Western blotting (<italic>lane 5</italic>&#8242;). A control experiment was performed in the absence of immobilized MacB in which &#916;20MacA was passed through a Ni<sup>2+</sup>-agarose column and the flow-through (<italic>lane 7</italic>), the first and second washes with 100 m<sc>m</sc> imidazole (<italic>lanes 8</italic> and <italic>9</italic>, respectively), and the 500 m<sc>m</sc> imidazole elution (<italic>lane 10</italic>) were tested for the presence of MacA, which was only found in the flow-through and first wash (<italic>lane 7</italic>&#8242; and <italic>8</italic>&#8242;, respectively), establishing that S-tagged MacA does not bind to the column. These results indicate that MacA does not require the N-terminal &#945;-helix, which anchors it to the inner membrane, to interact with MacB. A protein <italic>M</italic><sub>r</sub> marker was run in <italic>lane 6.</italic></p></caption>
###xml 5663 5663 5647 5647 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0040961340001"/>
###xml 0 5663 0 5647 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="24"><bold>MacA interacts with both MacB and TolC.</bold><italic>A,</italic> overexpression and purification of MacA, MacB, and TolC. An SDS-polyacrylamide gel of purified MacB (<italic>lane 1</italic>), MacA (<italic>lane 2</italic>), and TolC (<italic>lane 3</italic>) is shown. The purified His-tagged MacB and TolC proteins were used as bait, immobilized on a Ni<sup>2+</sup>-agarose column, over which a slurry of either detergent-solubilized membranes (<italic>e.g.</italic> from strains overexpressing S-tagged MacA or TolC) or soluble proteins (<italic>e.g.</italic> from strains overexpressing S-tagged &#916;20MacA) was passed to test whether the cognate proteins from the tripartite pump could be pulled out of this complex mixture of proteins. <italic>B,</italic> pulldown of MacA by MacB. <italic>1st</italic> and <italic>2nd lanes,</italic> SDS-polyacrylamide gel of immobilized His-tagged MacB (<italic>1st lane</italic>) and the detergent-solubilized membranes from cells overexpressing the S-tagged MacA (<italic>2nd lane</italic>). <italic>3rd</italic> to <italic>11th lanes,</italic> Western blot using antibodies to the S-tag (1:5000 dilution) on MacA. The pulldown assay was performed with His-tagged MacB immobilized on a Ni<sup>2+</sup>-agarose column, over which a slurry of detergent-solubilized membranes from cells overexpressing S-tagged MacA was passed (<italic>7th</italic> to <italic>9th lanes</italic>). The flow-through (<italic>9th lane</italic>), 100 m<sc>m</sc> imidazole wash (<italic>8th lane</italic>), and the 500 m<sc>m</sc> imidazole elution (<italic>7th lane</italic>) were tested for the presence of MacA, which was now also detected in the elution fraction, indicating that it was bound to MacB. A negative control experiment was performed in the absence of immobilized MacB in which MacA was passed through a Ni<sup>2+</sup>-agarose column (<italic>3rd</italic> to <italic>5th lanes</italic>), and the flow-through (<italic>5th lane</italic>), 100 m<sc>m</sc> imidazole wash (<italic>4th lane</italic>), and the 500 m<sc>m</sc> imidazole elution (<italic>3rd lane</italic>) were tested for the presence of MacA, which was only found in the flow-through (<italic>5th lane</italic>), establishing that S-tagged MacA does not bind to the column. These results indicate that MacB can pull MacA from a complex mixture of membrane proteins. Purified His-tagged MacB did not cross-react with the antibodies to the S-tag (<italic>10th lane</italic>). <italic>C,</italic> pulldown of MacA by TolC. An SDS-polyacrylamide gel (<italic>lanes 1-8</italic>) for the pulldown of S-tagged MacA by His-tagged TolC and the corresponding Western blot (<italic>lanes 1</italic>&#8242;<italic>-8</italic>&#8242;) probed with antibodies (1:5000 dilution) to the S-tag on MacA. Purified His-tagged TolC was immobilized on a Ni<sup>2+</sup>-agarose column (<italic>lanes 1</italic> and <italic>1</italic>&#8242;); a slurry of detergent-solubilized membranes from cells overexpressing S-tagged MacA was passed through the column and the proteins in the flow-through (<italic>lane 2</italic> and <italic>2</italic>&#8242;), released by washing the column with 100 m<sc>m</sc> imidazole (<italic>lanes 3</italic> and <italic>3</italic>&#8242;) and eluted with 500 m<sc>m</sc> imidazole (<italic>lanes 4</italic> and <italic>4</italic>&#8242;), were detected. As a negative control, S-tagged MacA was passed through the column (<italic>lanes 6</italic> and <italic>6</italic>&#8242;), in the absence of immobilized TolC, and the column was washed with 100 m<sc>m</sc> (<italic>lanes 7</italic> and <italic>7</italic>&#8242;) and 500 m<sc>m</sc> (<italic>lanes 8</italic> and <italic>8</italic>&#8242;). Comparing <italic>lane 4</italic>&#8242; and <italic>8</italic>&#8242; demonstrates that MacA is only bound to the column in the presence of TolC, indicative of its interaction with TolC. <italic>D,</italic> pulldown of TolC by MacB. An SDS-polyacrylamide gel (<italic>lanes 1-4</italic>) for the pulldown of S-tagged TolC by His-tagged MacB and the corresponding Western blot (<italic>lanes 1</italic>&#8242;<italic>-4</italic>&#8242;) probed with antibodies (1:5000 dilution) to the S-tag on TolC. Purified His-tagged MacB was immobilized on a Ni<sup>2+</sup>-agarose column (<italic>lanes 1</italic> and <italic>1</italic>&#8242;), and a slurry of detergent-solubilized membranes from cells overexpressing S-tagged TolC was passed through the column (<italic>lane 3</italic> and <italic>3</italic>&#8242;), which was then washed with 75 m<sc>m</sc> imidazole (<italic>lanes 4</italic> and <italic>4</italic>&#8242;), and bound proteins were eluted with 500 m<sc>m</sc> imidazole (<italic>lanes 5</italic> and <italic>5</italic>&#8242;). A weak band, which was not present in the absence of immobilized MacB, was apparent in <italic>lane 5</italic>&#8242;, indicative of a weak interaction between MacB and TolC. A control experiment was performed in the absence of immobilized MacB in which T<italic>o</italic>lC was passed through a Ni<sup>2+</sup>-agarose column and the flow-through (<italic>lane 6</italic>), the 100 m<sc>m</sc> imidazole wash (<italic>lane 7</italic>), and the 500 m<sc>m</sc> imidazole elution (<italic>lane 8</italic>) were tested for the presence of TolC, which was only found in the flow-through (<italic>lane 6</italic>&#8242;), establishing that S-tagged TolC does not bind to the column. A protein <italic>M</italic><sub>r</sub> marker was run in <italic>lane 2. E,</italic> pulldown of N-terminal truncated MacA by MacB. An SDS-polyacrylamide gel shows the His-tagged MacB (<italic>lane 1</italic>) that was immobilized on a Ni<sup>2+</sup>-agarose column (<italic>lane 1</italic>), a slurry of cytoplasmic proteins released by disruption of cells overexpressing S-tagged &#916;20-MacA (<italic>lane 2</italic>), which was passed through the column, over immobilized MacB, and the proteins in the flow-through detected (<italic>lane 3</italic>); the proteins were released by washing the column with 100 m<sc>m</sc> imidazole (<italic>lane 4</italic>); and the proteins were eluted with 500 m<sc>m</sc> imidazole (<italic>lane 5</italic>). A Western blot was performed on each of the corresponding protein fractions (indicated with <italic>1</italic>&#8242;<italic>-5</italic>&#8242;) using antibodies to the S-tag (1:5000 dilution) to detect S-tagged MacA. The elution of MacB yields an extra, low <italic>M</italic><sub>r</sub>, band on the SDS-polyacrylamide gel that corresponds to that expected for MacA (<italic>lane 5</italic>) and was identified as such by Western blotting (<italic>lane 5</italic>&#8242;). A control experiment was performed in the absence of immobilized MacB in which &#916;20MacA was passed through a Ni<sup>2+</sup>-agarose column and the flow-through (<italic>lane 7</italic>), the first and second washes with 100 m<sc>m</sc> imidazole (<italic>lanes 8</italic> and <italic>9</italic>, respectively), and the 500 m<sc>m</sc> imidazole elution (<italic>lane 10</italic>) were tested for the presence of MacA, which was only found in the flow-through and first wash (<italic>lane 7</italic>&#8242; and <italic>8</italic>&#8242;, respectively), establishing that S-tagged MacA does not bind to the column. These results indicate that MacA does not require the N-terminal &#945;-helix, which anchors it to the inner membrane, to interact with MacB. A protein <italic>M</italic><sub>r</sub> marker was run in <italic>lane 6.</italic></p></caption><graphic xlink:href="zbc0040961340001"/></fig>
FIGURE 1.MacA interacts with both MacB and TolC.A, overexpression and purification of MacA, MacB, and TolC. An SDS-polyacrylamide gel of purified MacB (lane 1), MacA (lane 2), and TolC (lane 3) is shown. The purified His-tagged MacB and TolC proteins were used as bait, immobilized on a Ni2+-agarose column, over which a slurry of either detergent-solubilized membranes (e.g. from strains overexpressing S-tagged MacA or TolC) or soluble proteins (e.g. from strains overexpressing S-tagged Delta20MacA) was passed to test whether the cognate proteins from the tripartite pump could be pulled out of this complex mixture of proteins. B, pulldown of MacA by MacB. 1st and 2nd lanes, SDS-polyacrylamide gel of immobilized His-tagged MacB (1st lane) and the detergent-solubilized membranes from cells overexpressing the S-tagged MacA (2nd lane). 3rd to 11th lanes, Western blot using antibodies to the S-tag (1:5000 dilution) on MacA. The pulldown assay was performed with His-tagged MacB immobilized on a Ni2+-agarose column, over which a slurry of detergent-solubilized membranes from cells overexpressing S-tagged MacA was passed (7th to 9th lanes). The flow-through (9th lane), 100 mm imidazole wash (8th lane), and the 500 mm imidazole elution (7th lane) were tested for the presence of MacA, which was now also detected in the elution fraction, indicating that it was bound to MacB. A negative control experiment was performed in the absence of immobilized MacB in which MacA was passed through a Ni2+-agarose column (3rd to 5th lanes), and the flow-through (5th lane), 100 mm imidazole wash (4th lane), and the 500 mm imidazole elution (3rd lane) were tested for the presence of MacA, which was only found in the flow-through (5th lane), establishing that S-tagged MacA does not bind to the column. These results indicate that MacB can pull MacA from a complex mixture of membrane proteins. Purified His-tagged MacB did not cross-react with the antibodies to the S-tag (10th lane). C, pulldown of MacA by TolC. An SDS-polyacrylamide gel (lanes 1-8) for the pulldown of S-tagged MacA by His-tagged TolC and the corresponding Western blot (lanes 1'-8') probed with antibodies (1:5000 dilution) to the S-tag on MacA. Purified His-tagged TolC was immobilized on a Ni2+-agarose column (lanes 1 and 1'); a slurry of detergent-solubilized membranes from cells overexpressing S-tagged MacA was passed through the column and the proteins in the flow-through (lane 2 and 2'), released by washing the column with 100 mm imidazole (lanes 3 and 3') and eluted with 500 mm imidazole (lanes 4 and 4'), were detected. As a negative control, S-tagged MacA was passed through the column (lanes 6 and 6'), in the absence of immobilized TolC, and the column was washed with 100 mm (lanes 7 and 7') and 500 mm (lanes 8 and 8'). Comparing lane 4' and 8' demonstrates that MacA is only bound to the column in the presence of TolC, indicative of its interaction with TolC. D, pulldown of TolC by MacB. An SDS-polyacrylamide gel (lanes 1-4) for the pulldown of S-tagged TolC by His-tagged MacB and the corresponding Western blot (lanes 1'-4') probed with antibodies (1:5000 dilution) to the S-tag on TolC. Purified His-tagged MacB was immobilized on a Ni2+-agarose column (lanes 1 and 1'), and a slurry of detergent-solubilized membranes from cells overexpressing S-tagged TolC was passed through the column (lane 3 and 3'), which was then washed with 75 mm imidazole (lanes 4 and 4'), and bound proteins were eluted with 500 mm imidazole (lanes 5 and 5'). A weak band, which was not present in the absence of immobilized MacB, was apparent in lane 5', indicative of a weak interaction between MacB and TolC. A control experiment was performed in the absence of immobilized MacB in which TolC was passed through a Ni2+-agarose column and the flow-through (lane 6), the 100 mm imidazole wash (lane 7), and the 500 mm imidazole elution (lane 8) were tested for the presence of TolC, which was only found in the flow-through (lane 6'), establishing that S-tagged TolC does not bind to the column. A protein Mr marker was run in lane 2. E, pulldown of N-terminal truncated MacA by MacB. An SDS-polyacrylamide gel shows the His-tagged MacB (lane 1) that was immobilized on a Ni2+-agarose column (lane 1), a slurry of cytoplasmic proteins released by disruption of cells overexpressing S-tagged Delta20-MacA (lane 2), which was passed through the column, over immobilized MacB, and the proteins in the flow-through detected (lane 3); the proteins were released by washing the column with 100 mm imidazole (lane 4); and the proteins were eluted with 500 mm imidazole (lane 5). A Western blot was performed on each of the corresponding protein fractions (indicated with 1'-5') using antibodies to the S-tag (1:5000 dilution) to detect S-tagged MacA. The elution of MacB yields an extra, low Mr, band on the SDS-polyacrylamide gel that corresponds to that expected for MacA (lane 5) and was identified as such by Western blotting (lane 5'). A control experiment was performed in the absence of immobilized MacB in which Delta20MacA was passed through a Ni2+-agarose column and the flow-through (lane 7), the first and second washes with 100 mm imidazole (lanes 8 and 9, respectively), and the 500 mm imidazole elution (lane 10) were tested for the presence of MacA, which was only found in the flow-through and first wash (lane 7' and 8', respectively), establishing that S-tagged MacA does not bind to the column. These results indicate that MacA does not require the N-terminal alpha-helix, which anchors it to the inner membrane, to interact with MacB. A protein Mr marker was run in lane 6.
###end p 23
###begin p 24
###xml 0 39 0 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MacA interacts with both MacB and TolC.</bold>
###xml 39 41 39 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 143 149 143 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 158 164 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 2</italic>
###xml 177 183 177 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 280 282 280 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 362 366 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 439 443 439 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 624 626 620 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 653 656 649 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1st</italic>
###xml 661 671 657 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2nd lanes,</italic>
###xml 727 735 723 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1st lane</italic>
###xml 822 830 818 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2nd lane</italic>
###xml 833 836 829 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3rd</italic>
###xml 840 851 836 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">11th lanes,</italic>
###xml 995 997 991 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1121 1124 1117 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">7th</italic>
###xml 1128 1137 1124 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">9th lanes</italic>
###xml 1158 1166 1154 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">9th lane</italic>
###xml 1174 1175 1170 1171 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1192 1200 1188 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8th lane</italic>
###xml 1216 1217 1212 1213 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1237 1245 1233 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">7th lane</italic>
###xml 1492 1494 1488 1490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1511 1514 1507 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3rd</italic>
###xml 1518 1527 1514 1523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5th lanes</italic>
###xml 1552 1560 1548 1556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5th lane</italic>
###xml 1568 1569 1564 1565 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1586 1594 1582 1590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4th lane</italic>
###xml 1610 1611 1606 1607 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1631 1639 1627 1635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3rd lane</italic>
###xml 1721 1729 1717 1725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5th lane</italic>
###xml 1964 1973 1960 1969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10th lane</italic>
###xml 1976 1978 1972 1974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 2032 2041 2028 2037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1-8</italic>
###xml 2132 2139 2128 2135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 2140 2142 2136 2138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-8</italic>
###xml 2256 2258 2252 2254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 2275 2282 2271 2278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 2287 2288 2283 2284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 2444 2450 2440 2446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 2</italic>
###xml 2455 2456 2451 2452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 2501 2502 2497 2498 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2514 2521 2510 2517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3</italic>
###xml 2526 2527 2522 2523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 2551 2552 2547 2548 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2564 2571 2560 2567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 4</italic>
###xml 2576 2577 2572 2573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 2664 2671 2660 2667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 6</italic>
###xml 2676 2677 2672 2673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 2753 2754 2749 2750 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2756 2763 2752 2759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 7</italic>
###xml 2768 2769 2764 2765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">7</italic>
###xml 2781 2782 2777 2778 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2784 2791 2780 2787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 8</italic>
###xml 2796 2797 2792 2793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8</italic>
###xml 2811 2817 2807 2813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 2823 2824 2819 2820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8</italic>
###xml 2943 2945 2939 2941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D,</italic>
###xml 2999 3008 2995 3004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1-4</italic>
###xml 3099 3106 3095 3102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 3107 3109 3103 3105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-4</italic>
###xml 3223 3225 3219 3221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 3242 3249 3238 3245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 3254 3255 3250 3251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 3378 3384 3374 3380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 3389 3390 3385 3386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 3425 3426 3421 3422 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3438 3445 3434 3441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 4</italic>
###xml 3450 3451 3446 3447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 3496 3497 3492 3493 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3509 3516 3505 3512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 5</italic>
###xml 3521 3522 3517 3518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 3613 3619 3609 3615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 3758 3759 3754 3755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">o</italic>
###xml 3785 3787 3781 3783 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 3825 3831 3821 3827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6</italic>
###xml 3843 3844 3839 3840 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3861 3867 3857 3863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 7</italic>
###xml 3883 3884 3879 3880 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3904 3910 3900 3906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 8</italic>
###xml 3992 3998 3988 3994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6</italic>
###xml 4073 4074 4069 4070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 4074 4075 4070 4071 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 4094 4104 4090 4100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 2. E,</italic>
###xml 4205 4211 4201 4207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 4241 4243 4237 4239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 4260 4266 4256 4262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 4372 4378 4364 4370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 2</italic>
###xml 4488 4494 4480 4486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 4556 4557 4548 4549 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 4569 4575 4561 4567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 4617 4618 4609 4610 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 4630 4636 4622 4628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 4731 4732 4723 4724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 4733 4735 4725 4727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-5</italic>
###xml 4852 4853 4844 4845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 4853 4854 4845 4846 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 4935 4941 4927 4933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 4991 4997 4983 4989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 5115 5117 5103 5105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 5155 5161 5143 5149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 7</italic>
###xml 5202 5203 5190 5191 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 5215 5222 5203 5210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 8</italic>
###xml 5227 5228 5215 5216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">9</italic>
###xml 5258 5259 5246 5247 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 5279 5286 5267 5274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 10</italic>
###xml 5383 5389 5371 5377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 7</italic>
###xml 5395 5396 5383 5384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8</italic>
###xml 5626 5627 5610 5611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 5627 5628 5611 5612 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 5647 5654 5631 5638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6.</italic>
MacA interacts with both MacB and TolC.A, overexpression and purification of MacA, MacB, and TolC. An SDS-polyacrylamide gel of purified MacB (lane 1), MacA (lane 2), and TolC (lane 3) is shown. The purified His-tagged MacB and TolC proteins were used as bait, immobilized on a Ni2+-agarose column, over which a slurry of either detergent-solubilized membranes (e.g. from strains overexpressing S-tagged MacA or TolC) or soluble proteins (e.g. from strains overexpressing S-tagged Delta20MacA) was passed to test whether the cognate proteins from the tripartite pump could be pulled out of this complex mixture of proteins. B, pulldown of MacA by MacB. 1st and 2nd lanes, SDS-polyacrylamide gel of immobilized His-tagged MacB (1st lane) and the detergent-solubilized membranes from cells overexpressing the S-tagged MacA (2nd lane). 3rd to 11th lanes, Western blot using antibodies to the S-tag (1:5000 dilution) on MacA. The pulldown assay was performed with His-tagged MacB immobilized on a Ni2+-agarose column, over which a slurry of detergent-solubilized membranes from cells overexpressing S-tagged MacA was passed (7th to 9th lanes). The flow-through (9th lane), 100 mm imidazole wash (8th lane), and the 500 mm imidazole elution (7th lane) were tested for the presence of MacA, which was now also detected in the elution fraction, indicating that it was bound to MacB. A negative control experiment was performed in the absence of immobilized MacB in which MacA was passed through a Ni2+-agarose column (3rd to 5th lanes), and the flow-through (5th lane), 100 mm imidazole wash (4th lane), and the 500 mm imidazole elution (3rd lane) were tested for the presence of MacA, which was only found in the flow-through (5th lane), establishing that S-tagged MacA does not bind to the column. These results indicate that MacB can pull MacA from a complex mixture of membrane proteins. Purified His-tagged MacB did not cross-react with the antibodies to the S-tag (10th lane). C, pulldown of MacA by TolC. An SDS-polyacrylamide gel (lanes 1-8) for the pulldown of S-tagged MacA by His-tagged TolC and the corresponding Western blot (lanes 1'-8') probed with antibodies (1:5000 dilution) to the S-tag on MacA. Purified His-tagged TolC was immobilized on a Ni2+-agarose column (lanes 1 and 1'); a slurry of detergent-solubilized membranes from cells overexpressing S-tagged MacA was passed through the column and the proteins in the flow-through (lane 2 and 2'), released by washing the column with 100 mm imidazole (lanes 3 and 3') and eluted with 500 mm imidazole (lanes 4 and 4'), were detected. As a negative control, S-tagged MacA was passed through the column (lanes 6 and 6'), in the absence of immobilized TolC, and the column was washed with 100 mm (lanes 7 and 7') and 500 mm (lanes 8 and 8'). Comparing lane 4' and 8' demonstrates that MacA is only bound to the column in the presence of TolC, indicative of its interaction with TolC. D, pulldown of TolC by MacB. An SDS-polyacrylamide gel (lanes 1-4) for the pulldown of S-tagged TolC by His-tagged MacB and the corresponding Western blot (lanes 1'-4') probed with antibodies (1:5000 dilution) to the S-tag on TolC. Purified His-tagged MacB was immobilized on a Ni2+-agarose column (lanes 1 and 1'), and a slurry of detergent-solubilized membranes from cells overexpressing S-tagged TolC was passed through the column (lane 3 and 3'), which was then washed with 75 mm imidazole (lanes 4 and 4'), and bound proteins were eluted with 500 mm imidazole (lanes 5 and 5'). A weak band, which was not present in the absence of immobilized MacB, was apparent in lane 5', indicative of a weak interaction between MacB and TolC. A control experiment was performed in the absence of immobilized MacB in which TolC was passed through a Ni2+-agarose column and the flow-through (lane 6), the 100 mm imidazole wash (lane 7), and the 500 mm imidazole elution (lane 8) were tested for the presence of TolC, which was only found in the flow-through (lane 6'), establishing that S-tagged TolC does not bind to the column. A protein Mr marker was run in lane 2. E, pulldown of N-terminal truncated MacA by MacB. An SDS-polyacrylamide gel shows the His-tagged MacB (lane 1) that was immobilized on a Ni2+-agarose column (lane 1), a slurry of cytoplasmic proteins released by disruption of cells overexpressing S-tagged Delta20-MacA (lane 2), which was passed through the column, over immobilized MacB, and the proteins in the flow-through detected (lane 3); the proteins were released by washing the column with 100 mm imidazole (lane 4); and the proteins were eluted with 500 mm imidazole (lane 5). A Western blot was performed on each of the corresponding protein fractions (indicated with 1'-5') using antibodies to the S-tag (1:5000 dilution) to detect S-tagged MacA. The elution of MacB yields an extra, low Mr, band on the SDS-polyacrylamide gel that corresponds to that expected for MacA (lane 5) and was identified as such by Western blotting (lane 5'). A control experiment was performed in the absence of immobilized MacB in which Delta20MacA was passed through a Ni2+-agarose column and the flow-through (lane 7), the first and second washes with 100 mm imidazole (lanes 8 and 9, respectively), and the 500 mm imidazole elution (lane 10) were tested for the presence of MacA, which was only found in the flow-through and first wash (lane 7' and 8', respectively), establishing that S-tagged MacA does not bind to the column. These results indicate that MacA does not require the N-terminal alpha-helix, which anchors it to the inner membrane, to interact with MacB. A protein Mr marker was run in lane 6.
###end p 24
###begin p 25
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mass Spectrometry</italic>
Mass Spectrometry-Analyses were performed in a nanoflow ES mass spectrometer Q-ToF2 (Micromass). The following experimental parameters were used to record mass spectra of 2 mg/ml MacB in the Q-ToF2 instrument: needle voltage of 1.5 kV and MCP 2350 V.
###end p 25
###begin p 26
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atomic Force Microscopy</italic>
Atomic Force Microscopy-MacB was diluted to a final concentration of 1 mug/ml, and 45 mul of the sample was allowed to adsorb to freshly cleaved mica. Imaging in air was performed with a Multimode atomic force microscope (Digital Instruments, Santa Barbara, CA) in tapping mode. The silicon cantilevers containing a diamond-like extratip had a drive frequency of approximately300 kHz and a specified spring constant of 40 newtons/m (MikroMasch, Portland, OR), and the applied imaging force was kept as low as possible (target amplitude approximately1.6-1.8 V and amplitude set-point approximately1.3-1.5 V). The molecular volumes of the protein particles were determined from particle dimensions based on AFM images (see supplemental material).
###end p 26
###begin p 27
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATPase Assays</italic>
###xml 249 250 248 249 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 314 315 313 314 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 339 340 338 339 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 345 346 344 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 396 398 395 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 476 478 475 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 553 554 552 553 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
ATPase Assays-An EnzChek phosphate assay kit (Invitrogen) was used to determine the ATPase activity of MacB hydrolyzing MgATP to release phosphate, when the reactants were mixed in a stopped-flow device (see supplemental material). Generally, 2.3 mum protein was mixed with varying concentrations of ATP, up to 4 mm, in the presence of 6 mm MgCl2, to ensure that all the ATP was complexed with Mg2+. In control experiments, no ATPase activity was apparent in the absence of Mg2+. Generally, for MacB alone, the hydrolysis of ATP was characterized by a Pi burst, which was of near equivalence to the MacB concentration, consistent with the ATPase activity being attributable to MacB, rather than any contaminant proteins.
###end p 27
###begin p 28
###xml 0 72 0 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Quantification of Erythromycin Binding to Affinity-purified Mac Proteins</italic>
###xml 101 109 101 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-methyl</italic>
###xml 110 112 110 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
Quantification of Erythromycin Binding to Affinity-purified Mac Proteins-The equilibrium binding of [N-methyl-14C]erythromycin to purified Mac proteins was determined by rapid filtration and quantification of the radioactivity remaining on 0.2-mum filters as outlined in the supplemental material.
###end p 28
###begin title 29
RESULTS
###end title 29
###begin p 30
###xml 0 65 0 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacA Interacts with Both MacB and TolC via Its Periplasmic Domain</italic>
###xml 87 94 87 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 186 192 186 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 228 229 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 222 229 222 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 301 302 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 321 322 321 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 315 322 315 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 390 391 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 384 391 384 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 519 520 515 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 513 520 509 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>E</italic></xref>
###xml 87 94 <span type="species:ncbi:562">E. coli</span>
MacA Interacts with Both MacB and TolC via Its Periplasmic Domain-Interactions between E. coli MacA, MacB, and TolC were tested using detergent-solubilized proteins for pulldown assays (Fig. 1). MacA interacted with MacB (Fig. 1B), which we confirmed by cross-linking the proteins (supplemental Fig. 2A), and TolC (Fig. 1C). Although we detected an interaction between TolC and MacB (Fig. 1D), the intensity of the band suggested a weak interaction. N-terminal truncated MacA (Delta20-MacA) interacted with MacB (Fig. 1E), indicating that it is the periplasmic domains of these proteins that interact. The fact that in each case the cognate pump protein could be pulled out of a complex mixture of detergent-solubilized proteins from membranes or cells indicated that the interactions are specific.
###end p 30
###begin p 31
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 86 9 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MacAB-TolC form a tripartite complex that confers resistance to erythromycin.</bold>
###xml 86 88 86 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 107 114 107 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 426 438 362 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B, bar chart</italic>
###xml 489 496 425 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 595 600 530 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blank</italic>
###xml 617 621 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacB</italic>
###xml 665 669 600 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wild</italic>
###xml 692 693 627 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 693 696 628 631 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 9 1058 9 993 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32"><bold>MacAB-TolC form a tripartite complex that confers resistance to erythromycin.</bold><italic>A,</italic> growth curves for <italic>E. coli</italic> cells, of strain KAM3 (DE3), harboring the plasmids pETDuet (&#8226;), pETDuet-MacB (&#9675;), pETDuet-MacB/MacA (&#9662;), pETDuet-MacB/TolC (&#9653;), pETDuet-MacB/MacA/TolC (&#9642;) and pETDuet-MacB/gIII-SS-&#916;20MacA/TolC (&#9633;) grown in the presence of 100 &#956;g/ml erythromycin. <italic>B, bar chart</italic> showing the extent of inhibition of the growth of <italic>E. coli</italic> cells in response to 50 &#956;g/ml erythromycin, of strain KAM3(DE3), harboring the plasmids pETDuet (<italic>blank</italic>), pETDuet-MacB (<italic>MacB</italic>), pETDuet-MacB/MacA (MacAB) or no plasmid (<italic>Wild</italic>). For each strain the <italic>A</italic><sub>600</sub> was determined after growth for 3 h in the absence and presence of erythromycin, and the growth inhibition was determined as the ratio of these measurements. Cells expressing both MacA and MacB suffered less from erythromycin growth inhibition than those expressing only MacB, suggesting that MacA confers elevated resistance to erythromycin on the MacB strain.</p>
###xml 9 1058 9 993 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32"><bold>MacAB-TolC form a tripartite complex that confers resistance to erythromycin.</bold><italic>A,</italic> growth curves for <italic>E. coli</italic> cells, of strain KAM3 (DE3), harboring the plasmids pETDuet (&#8226;), pETDuet-MacB (&#9675;), pETDuet-MacB/MacA (&#9662;), pETDuet-MacB/TolC (&#9653;), pETDuet-MacB/MacA/TolC (&#9642;) and pETDuet-MacB/gIII-SS-&#916;20MacA/TolC (&#9633;) grown in the presence of 100 &#956;g/ml erythromycin. <italic>B, bar chart</italic> showing the extent of inhibition of the growth of <italic>E. coli</italic> cells in response to 50 &#956;g/ml erythromycin, of strain KAM3(DE3), harboring the plasmids pETDuet (<italic>blank</italic>), pETDuet-MacB (<italic>MacB</italic>), pETDuet-MacB/MacA (MacAB) or no plasmid (<italic>Wild</italic>). For each strain the <italic>A</italic><sub>600</sub> was determined after growth for 3 h in the absence and presence of erythromycin, and the growth inhibition was determined as the ratio of these measurements. Cells expressing both MacA and MacB suffered less from erythromycin growth inhibition than those expressing only MacB, suggesting that MacA confers elevated resistance to erythromycin on the MacB strain.</p></caption>
###xml 1058 1058 993 993 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0040961340002"/>
###xml 0 1058 0 993 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="32"><bold>MacAB-TolC form a tripartite complex that confers resistance to erythromycin.</bold><italic>A,</italic> growth curves for <italic>E. coli</italic> cells, of strain KAM3 (DE3), harboring the plasmids pETDuet (&#8226;), pETDuet-MacB (&#9675;), pETDuet-MacB/MacA (&#9662;), pETDuet-MacB/TolC (&#9653;), pETDuet-MacB/MacA/TolC (&#9642;) and pETDuet-MacB/gIII-SS-&#916;20MacA/TolC (&#9633;) grown in the presence of 100 &#956;g/ml erythromycin. <italic>B, bar chart</italic> showing the extent of inhibition of the growth of <italic>E. coli</italic> cells in response to 50 &#956;g/ml erythromycin, of strain KAM3(DE3), harboring the plasmids pETDuet (<italic>blank</italic>), pETDuet-MacB (<italic>MacB</italic>), pETDuet-MacB/MacA (MacAB) or no plasmid (<italic>Wild</italic>). For each strain the <italic>A</italic><sub>600</sub> was determined after growth for 3 h in the absence and presence of erythromycin, and the growth inhibition was determined as the ratio of these measurements. Cells expressing both MacA and MacB suffered less from erythromycin growth inhibition than those expressing only MacB, suggesting that MacA confers elevated resistance to erythromycin on the MacB strain.</p></caption><graphic xlink:href="zbc0040961340002"/></fig>
###xml 107 114 <span type="species:ncbi:562">E. coli</span>
###xml 489 496 <span type="species:ncbi:562">E. coli</span>
FIGURE 2.MacAB-TolC form a tripartite complex that confers resistance to erythromycin.A, growth curves for E. coli cells, of strain KAM3 (DE3), harboring the plasmids pETDuet (*), pETDuet-MacB (o), pETDuet-MacB/MacA (black triangle down), pETDuet-MacB/TolC (triangle up), pETDuet-MacB/MacA/TolC (blacksquare, square, filled) and pETDuet-MacB/gIII-SS-Delta20MacA/TolC (square) grown in the presence of 100 mug/ml erythromycin. B, bar chart showing the extent of inhibition of the growth of E. coli cells in response to 50 mug/ml erythromycin, of strain KAM3(DE3), harboring the plasmids pETDuet (blank), pETDuet-MacB (MacB), pETDuet-MacB/MacA (MacAB) or no plasmid (Wild). For each strain the A600 was determined after growth for 3 h in the absence and presence of erythromycin, and the growth inhibition was determined as the ratio of these measurements. Cells expressing both MacA and MacB suffered less from erythromycin growth inhibition than those expressing only MacB, suggesting that MacA confers elevated resistance to erythromycin on the MacB strain.
###end p 31
###begin p 32
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MacAB-TolC form a tripartite complex that confers resistance to erythromycin.</bold>
###xml 77 79 77 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 417 429 353 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B, bar chart</italic>
###xml 480 487 416 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 586 591 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blank</italic>
###xml 608 612 543 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacB</italic>
###xml 656 660 591 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wild</italic>
###xml 683 684 618 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 684 687 619 622 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 98 105 <span type="species:ncbi:562">E. coli</span>
###xml 480 487 <span type="species:ncbi:562">E. coli</span>
MacAB-TolC form a tripartite complex that confers resistance to erythromycin.A, growth curves for E. coli cells, of strain KAM3 (DE3), harboring the plasmids pETDuet (*), pETDuet-MacB (o), pETDuet-MacB/MacA (black triangle down), pETDuet-MacB/TolC (triangle up), pETDuet-MacB/MacA/TolC (blacksquare, square, filled) and pETDuet-MacB/gIII-SS-Delta20MacA/TolC (square) grown in the presence of 100 mug/ml erythromycin. B, bar chart showing the extent of inhibition of the growth of E. coli cells in response to 50 mug/ml erythromycin, of strain KAM3(DE3), harboring the plasmids pETDuet (blank), pETDuet-MacB (MacB), pETDuet-MacB/MacA (MacAB) or no plasmid (Wild). For each strain the A600 was determined after growth for 3 h in the absence and presence of erythromycin, and the growth inhibition was determined as the ratio of these measurements. Cells expressing both MacA and MacB suffered less from erythromycin growth inhibition than those expressing only MacB, suggesting that MacA confers elevated resistance to erythromycin on the MacB strain.
###end p 32
###begin p 33
###xml 0 57 0 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli MacA and MacB Form a Functional Complex with TolC</italic>
###xml 89 100 89 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">macA, macB,</italic>
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tolC</italic>
###xml 117 124 117 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 130 135 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">acrAB</italic>
###xml 149 151 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 250 251 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 244 251 240 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 271 275 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">macB</italic>
###xml 281 285 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tolC</italic>
###xml 366 377 362 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">macB, tolC,</italic>
###xml 382 386 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">macA</italic>
###xml 451 452 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 445 452 441 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 792 793 784 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 786 793 778 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 1046 1048 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 1226 1230 1218 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">macB</italic>
###xml 1243 1247 1235 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tolC</italic>
###xml 1251 1255 1243 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">macA</italic>
###xml 1716 1717 1708 1709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1710 1717 1702 1709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 1952 1953 1944 1945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1946 1953 1938 1945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 2144 2145 2136 2137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 0 7 <span type="species:ncbi:562">E. coli</span>
###xml 117 124 <span type="species:ncbi:562">E. coli</span>
E. coli MacA and MacB Form a Functional Complex with TolC-The simultaneous expression of macA, macB, and tolC in the E. coli DeltaacrAB strain KAM3 (26) conferred resistance to erythromycin, indicative of the formation of a functional complex (Fig. 2A). Cells expressing macB with tolC conferred modest resistance to erythromycin in comparison with cells expressing macB, tolC, and macA, indicating that MacA is required to couple MacB to TolC (Fig. 2A). We sought to test whether the N terminus of MacA, which incorporates an alpha-helix that could interact with MacB, is required for the functional assembly of the complex. A construct in which the gIII-signal sequence was fused to truncated MacA, targeting it to the periplasm, was capable of conferring resistance to erythromycin (Fig. 2A), indicating that the N-terminal domain is not essential for the assembly of the functional complex. This is consistent with a report that a truncated lipid-deficient AcrA derivative was functional as judged by resistance of the cells to erythromycin (27). MacB alone conferred elevated resistance to erythromycin, probably because of its ability to pump the antibiotic into the periplasm, but we consistently found that expressing macB with either tolC or macA conferred greater resistance. Consequently, we sought to test if MacA could enhance this ability. To overcome the difficulty in comparing the growth of cells overexpressing multiple proteins that tend to grow at different rates, we monitored the growth of cells in the presence and absence of erythromycin and determined the growth loss (for cells growing in the presence of erythromycin in comparison with cells growing in the absence of erythromycin) (Fig. 2B). This revealed a significant loss in growth of the cells expressing MacB compared with those expressing MacAB, indicating that the simultaneous expression of MacA and MacB increases the resistance of the cells to erythromycin (Fig. 2B), suggesting that MacA enhances the ability of MacB to confer antibiotic resistance. Similarly, a previous study reported that MacAB, but not MacB alone, conferred resistance to macrolides (3).
###end p 33
###begin p 34
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacB Forms Dimers</italic>
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 555 556 555 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 571 572 571 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
MacB Forms Dimers-MacB has an atypical structure for an ABC transporter as it is predicted to have an N-terminal cytoplasmic NBD, which is connected to a four-helix transmembrane domain, with a large periplasmic domain formed by the loops connecting helices 1 and 2 (3, 23). If MacB resembles other ABC transporters that use a pair of NBDs to bind ATP, then it should function as a dimer. However, many transporters, including ABC transporters, have 12 membrane-spanning helices; MacB could adopt a similar topology by forming trimers. Furthermore, AcrB (4, 5) and TolC (9), which assemble into a tripartite complex with AcrA, clearly form trimers. If the trimeric arrangement of the periplasmic domains in AcrB forms a necessary scaffold for binding of AcrA, so that it can effectively interact with TolC, then by analogy the periplasmic domain of MacB might also be forced into forming trimers when interacting with MacA and TolC.
###end p 34
###begin p 35
###xml 746 747 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
Therefore, we sought to determine the oligomeric state of MacB. Size-exclusion chromatography indicated that it forms higher order oligomers consistent with a dimer (data not shown), but such measurements are not only dependent upon the molecular weight but also the shape of the protein. Furthermore, there is a need to determine the number of detergent molecules complexed by the protein. Consequently, to determine whether the detergent-solubilized MacB was dimeric, we added a cross-linker to trap the oligomers; when we ran the cross-linked protein on an SDS-polyacrylamide gel, the most predominant band ran between the 120- and 160-kDa markers, indicative of a dimer, which has a calculated molecular mass of 145.8 kDa (supplemental Fig. 2B).
###end p 35
###begin p 36
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 9 55 9 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Biophysical evidence for MacB dimer formation.</bold>
###xml 55 57 55 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dots</italic>
###xml 302 312 302 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">solid line</italic>
###xml 337 349 337 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom panel</italic>
###xml 390 392 390 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 494 505 494 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panel</italic>
###xml 575 586 575 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 598 599 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 600 601 600 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 827 829 827 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 9 1013 9 1013 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="37"><bold>Biophysical evidence for MacB dimer formation.</bold><italic>A,</italic> AUC sedimentation equilibrium profiles of MacB. A representative sedimentation equilibrium profile from one of the runs (two different velocities of the same sample) is shown. Experimental data (<italic>dots</italic>) and fitted model for a 162.6-kDa particle (<italic>solid line</italic>) is shown for each. The <italic>bottom panel</italic> represents the residuals after fitting. <italic>B,</italic> AUC sedimentation velocity profiles of MacB are consistent with the formation of a stable dimer. The <italic>upper panel</italic> shows sedimentation profile curves at different time points, and the <italic>lower panel</italic> presents a <italic>c</italic>(<italic>s</italic>) size distribution analysis with solutions of the Lamm equation. The sedimentation coefficient is 6.8 S corresponding to an apparent molecular mass of 160 kDa, consistent with a dimer with about 16 detergent molecules bound. <italic>C,</italic> mass spectrum of MacB. The charge states corresponding to the peaks are graphed. The mass spectrum indicated a molecular mass for MacB of 145.96 kDa, which is consistent with a dimer.</p>
###xml 9 1013 9 1013 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="37"><bold>Biophysical evidence for MacB dimer formation.</bold><italic>A,</italic> AUC sedimentation equilibrium profiles of MacB. A representative sedimentation equilibrium profile from one of the runs (two different velocities of the same sample) is shown. Experimental data (<italic>dots</italic>) and fitted model for a 162.6-kDa particle (<italic>solid line</italic>) is shown for each. The <italic>bottom panel</italic> represents the residuals after fitting. <italic>B,</italic> AUC sedimentation velocity profiles of MacB are consistent with the formation of a stable dimer. The <italic>upper panel</italic> shows sedimentation profile curves at different time points, and the <italic>lower panel</italic> presents a <italic>c</italic>(<italic>s</italic>) size distribution analysis with solutions of the Lamm equation. The sedimentation coefficient is 6.8 S corresponding to an apparent molecular mass of 160 kDa, consistent with a dimer with about 16 detergent molecules bound. <italic>C,</italic> mass spectrum of MacB. The charge states corresponding to the peaks are graphed. The mass spectrum indicated a molecular mass for MacB of 145.96 kDa, which is consistent with a dimer.</p></caption>
###xml 1013 1013 1013 1013 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0040961340003"/>
###xml 0 1013 0 1013 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="37"><bold>Biophysical evidence for MacB dimer formation.</bold><italic>A,</italic> AUC sedimentation equilibrium profiles of MacB. A representative sedimentation equilibrium profile from one of the runs (two different velocities of the same sample) is shown. Experimental data (<italic>dots</italic>) and fitted model for a 162.6-kDa particle (<italic>solid line</italic>) is shown for each. The <italic>bottom panel</italic> represents the residuals after fitting. <italic>B,</italic> AUC sedimentation velocity profiles of MacB are consistent with the formation of a stable dimer. The <italic>upper panel</italic> shows sedimentation profile curves at different time points, and the <italic>lower panel</italic> presents a <italic>c</italic>(<italic>s</italic>) size distribution analysis with solutions of the Lamm equation. The sedimentation coefficient is 6.8 S corresponding to an apparent molecular mass of 160 kDa, consistent with a dimer with about 16 detergent molecules bound. <italic>C,</italic> mass spectrum of MacB. The charge states corresponding to the peaks are graphed. The mass spectrum indicated a molecular mass for MacB of 145.96 kDa, which is consistent with a dimer.</p></caption><graphic xlink:href="zbc0040961340003"/></fig>
FIGURE 3.Biophysical evidence for MacB dimer formation.A, AUC sedimentation equilibrium profiles of MacB. A representative sedimentation equilibrium profile from one of the runs (two different velocities of the same sample) is shown. Experimental data (dots) and fitted model for a 162.6-kDa particle (solid line) is shown for each. The bottom panel represents the residuals after fitting. B, AUC sedimentation velocity profiles of MacB are consistent with the formation of a stable dimer. The upper panel shows sedimentation profile curves at different time points, and the lower panel presents a c(s) size distribution analysis with solutions of the Lamm equation. The sedimentation coefficient is 6.8 S corresponding to an apparent molecular mass of 160 kDa, consistent with a dimer with about 16 detergent molecules bound. C, mass spectrum of MacB. The charge states corresponding to the peaks are graphed. The mass spectrum indicated a molecular mass for MacB of 145.96 kDa, which is consistent with a dimer.
###end p 36
###begin p 37
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Biophysical evidence for MacB dimer formation.</bold>
###xml 46 48 46 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dots</italic>
###xml 293 303 293 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">solid line</italic>
###xml 328 340 328 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom panel</italic>
###xml 381 383 381 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 485 496 485 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panel</italic>
###xml 566 577 566 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 589 590 589 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 591 592 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 818 820 818 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
Biophysical evidence for MacB dimer formation.A, AUC sedimentation equilibrium profiles of MacB. A representative sedimentation equilibrium profile from one of the runs (two different velocities of the same sample) is shown. Experimental data (dots) and fitted model for a 162.6-kDa particle (solid line) is shown for each. The bottom panel represents the residuals after fitting. B, AUC sedimentation velocity profiles of MacB are consistent with the formation of a stable dimer. The upper panel shows sedimentation profile curves at different time points, and the lower panel presents a c(s) size distribution analysis with solutions of the Lamm equation. The sedimentation coefficient is 6.8 S corresponding to an apparent molecular mass of 160 kDa, consistent with a dimer with about 16 detergent molecules bound. C, mass spectrum of MacB. The charge states corresponding to the peaks are graphed. The mass spectrum indicated a molecular mass for MacB of 145.96 kDa, which is consistent with a dimer.
###end p 37
###begin p 38
###xml 482 483 479 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 620 621 617 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 614 621 611 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 768 769 765 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 762 769 759 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 1098 1100 1092 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 1110 1112 1104 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 1278 1280 1272 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 1358 1360 1352 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 1538 1542 1532 1536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 1972 1973 1952 1953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1966 1973 1946 1953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>C</italic></xref>
To further confirm the basic oligomeric unit as a dimer, we used two other techniques, analytical ultracentrifugation (AUC) and electrospray mass spectrometry (ES-MS). For the AUC experiments, we reduced the betaDDM concentration to just below the critical micelle concentration to avoid the formation of micelles. To determine the detergent contribution in the buoyant mass of the protein-detergent complex, we used a series of different density buffers prepared using a range of D2O concentrations. The apparent molecular mass for MacB was determined from sedimentation equilibrium measurements to be 162.6 kDa (Fig. 3A) and from sedimentation velocity measurements to have a sedimentation coefficient of 6.8 S, corresponding to a molecular mass of 160.0 kDa (Fig. 3B). This molecular mass is greater than expected for monomeric and less than expected for trimeric MacB, complexed with bound detergent, but it is highly consistent with a MacB dimer to which about 16 betaDDM molecules are bound. Although the amount of detergent bound to the MacB dimer appears to be lower than reported for RND (28) and MF (29) transporters, this reflects the fact that in our experimental set-up the detergent contribution was actively suppressed using a solvent density matching technique (25). Our independent measurement of bound detergent using a calorimetric assay (30) indicated that, when the detergent concentration was close to the critical micelle concentration, the amount of bound detergent was similar to that of other membrane proteins (e.g. MacB solubilized in 0.05% w/v betaDDM bound 1.2 g of betaDDM/g of MacB, which is equivalent to a betaDDM:MacB molar ratio of 164:1). Electrospray-mass spectrometry (ES-MS) was used in nontandem configuration to determine accurately the molecular mass of the protein, under conditions that would dissociate the betaDDM, revealing a peak with a molecular mass of 145,961.25 +/- 20.57 Da that is consistent with a MacB dimer (Fig. 3C).
###end p 38
###begin p 39
###xml 69 70 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 61 76 61 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, <italic>A</italic> and <italic>D</italic></xref>
###xml 157 158 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 160 167 160 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 542 543 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 536 543 536 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
We also sought to visualize single particles of MacB by AFM (Fig. 4, A and D). Two populations were revealed with average molecular volumes of 118 and 238 nm3 (Fig. 4B). These would accommodate proteins of about 60-70 and 130-140 kDa, respectively. Furthermore, the larger particles could clearly be seen at higher resolution to consist of two protein domains that are highly suggestive of a dimer. We found that in the presence of AMP-PNP, a nonhydrolysable analogue of ATP, the ratio of dimers to monomers on the AFM grids increased (Fig. 4C), which would be consistent with the nucleotide stabilizing the interaction between monomers. Our findings are novel because detergent molecules tend to impair the resolution of AFM studies of detergent-solubilized membrane proteins; this implies that for MacB, we may be able to get information on the topology and stoichiometry of its assemblies with MacA and TolC. Indeed, under coincubation of MacA and MacB, we could clearly distinguish a significant distribution of particles with molecular volumes larger than those corresponding to MacB dimers, which is consistent with multiprotein complexes formed between both proteins (data not shown). Such promising data paves the way toward further characterization of membrane multiprotein complexes and could prove a powerful instrument for determining the stoichiometry of the tripartite assembly.
###end p 39
###begin p 40
###xml 0 42 0 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacA Regulates the ATPase Activity of MacB</italic>
###xml 409 410 406 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 462 463 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 545 546 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 539 546 536 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 636 637 633 634 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 865 867 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 919 920 916 917 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1114 1115 1111 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 1115 1118 1112 1115 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 1134 1136 1131 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1189 1190 1185 1186 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1198 1199 1194 1195 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1211 1212 1207 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1205 1212 1201 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 1277 1278 1272 1273 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1332 1333 1326 1327 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1668 1669 1662 1663 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1753 1754 1747 1748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1747 1754 1741 1748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1891 1892 1885 1886 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1890 1892 1884 1886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1902 1903 1895 1896 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2012 2013 2005 2006 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 2011 2013 2004 2006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 2209 2210 2202 2203 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2316 2317 2309 2310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 2317 2320 2310 2313 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 2353 2354 2346 2347 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 2352 2354 2345 2347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 2364 2365 2356 2357 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2367 2369 2359 2361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
MacA Regulates the ATPase Activity of MacB-MacB retained ATPase activity when detergent-solubilized, but this was detergent-dependent, being active in Triton X-100 but not in betaDDM (data not shown). The time course for hydrolysis of MgATP by MacB was determined in a stopped-flow spectrophotometer, using the dye 2-amino-6-mercapto-7-methylpurine riboside to monitor the production of inorganic phosphate (Pi). The time course was characterized by a burst in Pi production, during the first 20 s, followed by a slower steady-state rate (Fig. 5A). This kinetic behavior is consistent with the ATP being rapidly hydrolyzed, to produce Pi and ADP, but further turnovers are rate-limited either by a subsequent conformational change or the slow release of products. Because previous studies have established that the ATPase activity of MacB is inhibited by vanadate (24), which stabilizes bound ADP, this indicates that Pi is released before ADP, suggesting that ADP release is rate-limiting. The rate constant for the hydrolysis step was determined by fitting the burst phase to an exponential function, yielding a kcat value of 0.24 s-1, whereas the amplitude of the burst phase was 2.2 mum for 1 mm ATP (Fig. 5A). When the MacA and MacB concentrations were increased to 3.5 mum, the amplitude of the burst phase increased to 3.3 mum (data not shown), indicating that the burst is approximately equivalent to the MacB concentration and that both NBDs within the MacB dimer are functional. We did not notice any deviation from a single exponential that would indicate that these NBDs turn over ATP differentially. The steady-state phase was characterized by a rate of Pi production that increased in a hyperbolic manner with the ATP concentration (Fig. 5B); fitting the steady-state rate data to a hyperbolic function yielded a maximal specific activity of 8.9 nmol of ATP/min/mg MacB and a Km of 374 mum. A progressive reduction in the amplitude of the burst phase for ATP concentrations below the steady-state Km value hindered analyses because the pre-steady-state phase tended to merge with the steady-state phase; consequently, we only used the steady-state rates determined at ATP concentrations of 0.1 mm and above. For comparison, the lipid A transporter MsbA, an half-ABC transporter, was characterized by a Vmax of 37 nmol of ATP/min/mg and a Km of 878 mum (31).
###end p 40
###begin p 41
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 9 43 9 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">AFM analyses, AFM imaging of MacB.</bold>
###xml 43 45 43 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 251 252 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 257 258 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 318 319 306 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 335 337 323 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 443 444 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 449 450 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 494 495 480 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 497 498 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 523 524 507 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 526 527 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 589 591 573 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 762 763 744 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 765 766 747 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 790 791 770 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 793 794 773 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 890 892 870 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D,</italic>
###xml 957 958 937 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 959 960 939 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 9 1029 9 1009 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="42"><bold>AFM analyses, AFM imaging of MacB.</bold><italic>A,</italic> three-dimensional picture of a low magnification image of MacB acquired in air in Tapping Mode with a diamond-like extra tip of resonant frequency &#8764;300 kHz and spring constant of 40 newtons/m. <italic>m</italic> and <italic>d</italic> show particles that belong to the first and second peak in <italic>B</italic>, respectively. <italic>B,</italic> frequency distribution of molecular volumes of MacB. The curve indicates a fitted Gaussian function. The <italic>m</italic> and <italic>d</italic> peaks correspond to volumes of 118 &#177; 1 nm<sup>3</sup> (<italic>n</italic> = 1642) and 238 &#177; 5 nm<sup>3</sup> (<italic>n</italic> = 665), consistent with the monomer and dimer, respectively. <italic>C,</italic> frequency distribution of molecular volumes of MacB that had been incubated with the nonhydrolysable ATP analogue AMP-PNP. The peaks correspond to volumes of 112 &#177; 3 nm<sup>3</sup> (<italic>n</italic> = 94) and 218 &#177; 14 nm<sup>3</sup> (<italic>n</italic> = 116). These data indicate an increase in the dimer:monomer ratio in the presence of AMP-PNP. <italic>D,</italic> high resolution images of structures where two small particles (<italic>m</italic>+<italic>m</italic>) are attached to one another, clearly indicative of dimer formation.</p>
###xml 9 1029 9 1009 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="42"><bold>AFM analyses, AFM imaging of MacB.</bold><italic>A,</italic> three-dimensional picture of a low magnification image of MacB acquired in air in Tapping Mode with a diamond-like extra tip of resonant frequency &#8764;300 kHz and spring constant of 40 newtons/m. <italic>m</italic> and <italic>d</italic> show particles that belong to the first and second peak in <italic>B</italic>, respectively. <italic>B,</italic> frequency distribution of molecular volumes of MacB. The curve indicates a fitted Gaussian function. The <italic>m</italic> and <italic>d</italic> peaks correspond to volumes of 118 &#177; 1 nm<sup>3</sup> (<italic>n</italic> = 1642) and 238 &#177; 5 nm<sup>3</sup> (<italic>n</italic> = 665), consistent with the monomer and dimer, respectively. <italic>C,</italic> frequency distribution of molecular volumes of MacB that had been incubated with the nonhydrolysable ATP analogue AMP-PNP. The peaks correspond to volumes of 112 &#177; 3 nm<sup>3</sup> (<italic>n</italic> = 94) and 218 &#177; 14 nm<sup>3</sup> (<italic>n</italic> = 116). These data indicate an increase in the dimer:monomer ratio in the presence of AMP-PNP. <italic>D,</italic> high resolution images of structures where two small particles (<italic>m</italic>+<italic>m</italic>) are attached to one another, clearly indicative of dimer formation.</p></caption>
###xml 1029 1029 1009 1009 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0040961340004"/>
###xml 0 1029 0 1009 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="42"><bold>AFM analyses, AFM imaging of MacB.</bold><italic>A,</italic> three-dimensional picture of a low magnification image of MacB acquired in air in Tapping Mode with a diamond-like extra tip of resonant frequency &#8764;300 kHz and spring constant of 40 newtons/m. <italic>m</italic> and <italic>d</italic> show particles that belong to the first and second peak in <italic>B</italic>, respectively. <italic>B,</italic> frequency distribution of molecular volumes of MacB. The curve indicates a fitted Gaussian function. The <italic>m</italic> and <italic>d</italic> peaks correspond to volumes of 118 &#177; 1 nm<sup>3</sup> (<italic>n</italic> = 1642) and 238 &#177; 5 nm<sup>3</sup> (<italic>n</italic> = 665), consistent with the monomer and dimer, respectively. <italic>C,</italic> frequency distribution of molecular volumes of MacB that had been incubated with the nonhydrolysable ATP analogue AMP-PNP. The peaks correspond to volumes of 112 &#177; 3 nm<sup>3</sup> (<italic>n</italic> = 94) and 218 &#177; 14 nm<sup>3</sup> (<italic>n</italic> = 116). These data indicate an increase in the dimer:monomer ratio in the presence of AMP-PNP. <italic>D,</italic> high resolution images of structures where two small particles (<italic>m</italic>+<italic>m</italic>) are attached to one another, clearly indicative of dimer formation.</p></caption><graphic xlink:href="zbc0040961340004"/></fig>
FIGURE 4.AFM analyses, AFM imaging of MacB.A, three-dimensional picture of a low magnification image of MacB acquired in air in Tapping Mode with a diamond-like extra tip of resonant frequency approximately300 kHz and spring constant of 40 newtons/m. m and d show particles that belong to the first and second peak in B, respectively. B, frequency distribution of molecular volumes of MacB. The curve indicates a fitted Gaussian function. The m and d peaks correspond to volumes of 118 +/- 1 nm3 (n = 1642) and 238 +/- 5 nm3 (n = 665), consistent with the monomer and dimer, respectively. C, frequency distribution of molecular volumes of MacB that had been incubated with the nonhydrolysable ATP analogue AMP-PNP. The peaks correspond to volumes of 112 +/- 3 nm3 (n = 94) and 218 +/- 14 nm3 (n = 116). These data indicate an increase in the dimer:monomer ratio in the presence of AMP-PNP. D, high resolution images of structures where two small particles (m+m) are attached to one another, clearly indicative of dimer formation.
###end p 41
###begin p 42
###xml 0 34 0 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">AFM analyses, AFM imaging of MacB.</bold>
###xml 34 36 34 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 242 243 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 248 249 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 309 310 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 326 328 314 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 434 435 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 440 441 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 485 486 471 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 488 489 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 514 515 498 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 517 518 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 580 582 564 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 753 754 735 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 756 757 738 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 781 782 761 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 784 785 764 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 881 883 861 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D,</italic>
###xml 948 949 928 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 950 951 930 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
AFM analyses, AFM imaging of MacB.A, three-dimensional picture of a low magnification image of MacB acquired in air in Tapping Mode with a diamond-like extra tip of resonant frequency approximately300 kHz and spring constant of 40 newtons/m. m and d show particles that belong to the first and second peak in B, respectively. B, frequency distribution of molecular volumes of MacB. The curve indicates a fitted Gaussian function. The m and d peaks correspond to volumes of 118 +/- 1 nm3 (n = 1642) and 238 +/- 5 nm3 (n = 665), consistent with the monomer and dimer, respectively. C, frequency distribution of molecular volumes of MacB that had been incubated with the nonhydrolysable ATP analogue AMP-PNP. The peaks correspond to volumes of 112 +/- 3 nm3 (n = 94) and 218 +/- 14 nm3 (n = 116). These data indicate an increase in the dimer:monomer ratio in the presence of AMP-PNP. D, high resolution images of structures where two small particles (m+m) are attached to one another, clearly indicative of dimer formation.
###end p 42
###begin p 43
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 137 144 137 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 408 409 408 409 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 469 470 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 705 706 705 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 699 706 699 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1018 1019 1018 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 1019 1022 1019 1022 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 1044 1046 1044 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1133 1137 1133 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 1144 1146 1144 1146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1155 1156 1155 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1149 1156 1149 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1596 1597 1595 1596 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1630 1631 1629 1630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1624 1631 1623 1630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
When MacA was added to MacB, at an equivalent or higher concentration, with both proteins in detergent, no phosphate burst was observed (Fig. 5A). Considering that the detergent was present for both the ATPase assays with MacB and MacAB suggests that the burst phase is mechanistically important and cannot be attributed to the detergent modifying the behavior of MacB. Interestingly, although there was no Pi burst by MacB in the presence of MacA, there was a lag in Pi production; this could signify that a conformational change that precedes the hydrolysis step becomes rate-limiting for the first turnover. The steady-state rate of ATP hydrolysis by MacB, in the presence of MacA, was enhanced (Fig. 5B). At first glance, this behavior might appear consistent with MacA increasing the rate of ADP dissociation from MacB, so that this step was no longer rate-limiting. However, although MacA increased the specific activity of MacB from 8.9 to 12.3 nmol of ATP/mg MacB/min, which would correspond to an increase in kcat from 0.011 to 0.015 s-1, the steady-state rate did not exceed the rate for hydrolysis in the absence of MacA (e.g. 0.24 s-1) (Fig. 5B). Accordingly, the increase in the steady-state rate, which we attribute to product release, or a conformational change preceding this, would not be rapid enough to prevent the phosphate burst. It seems more likely that MacA also retards the rate of ATP hydrolysis, so that this process becomes slower than the rate of product release. Indeed, we found that the affinity of MacB for ATP was increased by more than 5-fold, from 374 to 72 mum, in the presence of MacA (Fig. 5B). If the effect of MacA was simply to enhance product release to a rate faster than that for nucleotide hydrolysis, then we would have expected a decrease in affinity for ATP. On the other hand, if MacA simply retarded nucleotide hydrolysis to a rate slower than product release, then the maximal steady-state rate would have decreased. Our data are consistent with MacA increasing the rate of product release, while decreasing the rate of hydrolysis to a similar rate to product release.
###end p 43
###begin p 44
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 205 206 201 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 534 536 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 731 733 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
In contrast to a previous study, which indicated that the ATPase activity of reconstituted MacB was not activated by N-terminal truncated MacA (24), we found that when MacB was mixed with Delta20-MacA no Pi burst was apparent (data not shown). In the same study, and consistent with our findings, N-terminal truncated MacA was shown to interact with MacB; however, in contrast to our findings, when MacB was expressed with N-terminal truncated MacA in erythromycin-susceptible cells, there was no increase in erythromycin resistance (24). The reason for the difference with our own findings is unclear; however, in the previous study the signal sequence of OmpA was used to target MacA, truncated at position 32, to the periplasm (24), raising the possibility that the shorter MacA sequence and/or the OmpA signal sequence interfered with the ability of MacA to affect the ATPase activity of MacB.
###end p 44
###begin p 45
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 9 52 9 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MacA regulates the ATPase activity of MacB.</bold>
###xml 52 54 52 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 86 87 86 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 210 211 209 210 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 235 236 234 235 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 257 268 256 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper trace</italic>
###xml 284 295 283 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower trace</italic>
###xml 389 390 388 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 446 448 443 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 470 471 464 465 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 511 512 505 506 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 544 546 538 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 569 570 563 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 645 656 639 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower curve</italic>
###xml 672 683 666 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper curve</italic>
###xml 755 756 749 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 756 759 750 753 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 765 766 759 760 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 764 766 758 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 833 834 822 823 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 928 929 912 913 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 9 1009 9 993 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="46"><bold>MacA regulates the ATPase activity of MacB.</bold><italic>A,</italic> time course for the change in P<sub>i</sub> concentration, corresponding to the absorbance change of the 2-amino-6-mercapto-7-methylpurine riboside in <italic>A</italic>, where 2.3 &#956;<sc>m</sc> MacB was mixed with 1 m<sc>m</sc> ATP in the absence (<italic>upper trace</italic>) and presence (<italic>lower trace</italic>) of an equivalent concentration of MacA. In the absence of MacA, MacB produced a phosphate (P<sub>i</sub>) burst, with a rate and amplitude of 0.235 (&#177;0.001) s<sup>-1</sup> and 2.20 (&#177;0.01) &#956;<sc>m</sc>, respectively. MacB did not produce a P<sub>i</sub> burst in the presence of MacA. <italic>B,</italic> steady-state rate of P<sub>i</sub> production by MacB as a function of the ATP concentration in the absence (<italic>lower curve</italic>) and presence (<italic>upper curve</italic>) of an equivalent concentration of MacA. The data are characterized by <italic>V</italic><sub>max</sub> and <italic>K<sub>m</sub></italic> values of 8.9 (&#177;0.7) nmol of ATP/mg MacB/min and 374 (&#177;126) &#956;<sc>m</sc>, respectively, for MacB alone; and of 12.3 (&#177;0.5) nmol of ATP/mg MacB/min and 72 (&#177;22) &#956;<sc>m</sc>, respectively, for MacB in the presence of an equivalent concentration of MacA.</p>
###xml 9 1009 9 993 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="46"><bold>MacA regulates the ATPase activity of MacB.</bold><italic>A,</italic> time course for the change in P<sub>i</sub> concentration, corresponding to the absorbance change of the 2-amino-6-mercapto-7-methylpurine riboside in <italic>A</italic>, where 2.3 &#956;<sc>m</sc> MacB was mixed with 1 m<sc>m</sc> ATP in the absence (<italic>upper trace</italic>) and presence (<italic>lower trace</italic>) of an equivalent concentration of MacA. In the absence of MacA, MacB produced a phosphate (P<sub>i</sub>) burst, with a rate and amplitude of 0.235 (&#177;0.001) s<sup>-1</sup> and 2.20 (&#177;0.01) &#956;<sc>m</sc>, respectively. MacB did not produce a P<sub>i</sub> burst in the presence of MacA. <italic>B,</italic> steady-state rate of P<sub>i</sub> production by MacB as a function of the ATP concentration in the absence (<italic>lower curve</italic>) and presence (<italic>upper curve</italic>) of an equivalent concentration of MacA. The data are characterized by <italic>V</italic><sub>max</sub> and <italic>K<sub>m</sub></italic> values of 8.9 (&#177;0.7) nmol of ATP/mg MacB/min and 374 (&#177;126) &#956;<sc>m</sc>, respectively, for MacB alone; and of 12.3 (&#177;0.5) nmol of ATP/mg MacB/min and 72 (&#177;22) &#956;<sc>m</sc>, respectively, for MacB in the presence of an equivalent concentration of MacA.</p></caption>
###xml 1009 1009 993 993 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0040961340005"/>
###xml 0 1009 0 993 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="46"><bold>MacA regulates the ATPase activity of MacB.</bold><italic>A,</italic> time course for the change in P<sub>i</sub> concentration, corresponding to the absorbance change of the 2-amino-6-mercapto-7-methylpurine riboside in <italic>A</italic>, where 2.3 &#956;<sc>m</sc> MacB was mixed with 1 m<sc>m</sc> ATP in the absence (<italic>upper trace</italic>) and presence (<italic>lower trace</italic>) of an equivalent concentration of MacA. In the absence of MacA, MacB produced a phosphate (P<sub>i</sub>) burst, with a rate and amplitude of 0.235 (&#177;0.001) s<sup>-1</sup> and 2.20 (&#177;0.01) &#956;<sc>m</sc>, respectively. MacB did not produce a P<sub>i</sub> burst in the presence of MacA. <italic>B,</italic> steady-state rate of P<sub>i</sub> production by MacB as a function of the ATP concentration in the absence (<italic>lower curve</italic>) and presence (<italic>upper curve</italic>) of an equivalent concentration of MacA. The data are characterized by <italic>V</italic><sub>max</sub> and <italic>K<sub>m</sub></italic> values of 8.9 (&#177;0.7) nmol of ATP/mg MacB/min and 374 (&#177;126) &#956;<sc>m</sc>, respectively, for MacB alone; and of 12.3 (&#177;0.5) nmol of ATP/mg MacB/min and 72 (&#177;22) &#956;<sc>m</sc>, respectively, for MacB in the presence of an equivalent concentration of MacA.</p></caption><graphic xlink:href="zbc0040961340005"/></fig>
FIGURE 5.MacA regulates the ATPase activity of MacB.A, time course for the change in Pi concentration, corresponding to the absorbance change of the 2-amino-6-mercapto-7-methylpurine riboside in A, where 2.3 mum MacB was mixed with 1 mm ATP in the absence (upper trace) and presence (lower trace) of an equivalent concentration of MacA. In the absence of MacA, MacB produced a phosphate (Pi) burst, with a rate and amplitude of 0.235 (+/-0.001) s-1 and 2.20 (+/-0.01) mum, respectively. MacB did not produce a Pi burst in the presence of MacA. B, steady-state rate of Pi production by MacB as a function of the ATP concentration in the absence (lower curve) and presence (upper curve) of an equivalent concentration of MacA. The data are characterized by Vmax and Km values of 8.9 (+/-0.7) nmol of ATP/mg MacB/min and 374 (+/-126) mum, respectively, for MacB alone; and of 12.3 (+/-0.5) nmol of ATP/mg MacB/min and 72 (+/-22) mum, respectively, for MacB in the presence of an equivalent concentration of MacA.
###end p 45
###begin p 46
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MacA regulates the ATPase activity of MacB.</bold>
###xml 43 45 43 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 77 78 77 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 201 202 200 201 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 226 227 225 226 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 248 259 247 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper trace</italic>
###xml 275 286 274 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower trace</italic>
###xml 380 381 379 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 437 439 434 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 461 462 455 456 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 502 503 496 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 535 537 529 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 560 561 554 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 636 647 630 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower curve</italic>
###xml 663 674 657 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper curve</italic>
###xml 746 747 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 747 750 741 744 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 756 757 750 751 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 755 757 749 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 824 825 813 814 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 919 920 903 904 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
MacA regulates the ATPase activity of MacB.A, time course for the change in Pi concentration, corresponding to the absorbance change of the 2-amino-6-mercapto-7-methylpurine riboside in A, where 2.3 mum MacB was mixed with 1 mm ATP in the absence (upper trace) and presence (lower trace) of an equivalent concentration of MacA. In the absence of MacA, MacB produced a phosphate (Pi) burst, with a rate and amplitude of 0.235 (+/-0.001) s-1 and 2.20 (+/-0.01) mum, respectively. MacB did not produce a Pi burst in the presence of MacA. B, steady-state rate of Pi production by MacB as a function of the ATP concentration in the absence (lower curve) and presence (upper curve) of an equivalent concentration of MacA. The data are characterized by Vmax and Km values of 8.9 (+/-0.7) nmol of ATP/mg MacB/min and 374 (+/-126) mum, respectively, for MacB alone; and of 12.3 (+/-0.5) nmol of ATP/mg MacB/min and 72 (+/-22) mum, respectively, for MacB in the presence of an equivalent concentration of MacA.
###end p 46
###begin p 47
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 6.</label>
###xml 9 66 9 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MacA increases the capacity of MacB to bind erythromycin.</bold>
###xml 184 192 181 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-methyl</italic>
###xml 193 195 190 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 256 257 252 253 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 323 327 319 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bars</italic>
###xml 370 381 366 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left, black</italic>
###xml 390 408 386 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">middle, light gray</italic>
###xml 422 438 418 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right, dark gray</italic>
###xml 9 514 9 510 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="48"><bold>MacA increases the capacity of MacB to bind erythromycin.</bold> Purified proteins (50 &#956;g of MacA or MacB, or 25 &#956;g of MacA plus 25 &#956;g of MacB) were incubated in the presence of [<italic>N-methyl</italic>-<sup>14</sup>C]erythromycin at concentrations as indicated (1, 5, or 10 &#956;<sc>m</sc>), after which drug binding was measured by rapid filtration. The <italic>bars</italic> represent the erythromycin bound by MacA (<italic>left, black</italic>), MacB (<italic>middle, light gray</italic>), and MacAB (<italic>right, dark gray</italic>). The data indicate that MacA enhances the binding of erythromycin to MacB.</p>
###xml 9 514 9 510 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="48"><bold>MacA increases the capacity of MacB to bind erythromycin.</bold> Purified proteins (50 &#956;g of MacA or MacB, or 25 &#956;g of MacA plus 25 &#956;g of MacB) were incubated in the presence of [<italic>N-methyl</italic>-<sup>14</sup>C]erythromycin at concentrations as indicated (1, 5, or 10 &#956;<sc>m</sc>), after which drug binding was measured by rapid filtration. The <italic>bars</italic> represent the erythromycin bound by MacA (<italic>left, black</italic>), MacB (<italic>middle, light gray</italic>), and MacAB (<italic>right, dark gray</italic>). The data indicate that MacA enhances the binding of erythromycin to MacB.</p></caption>
###xml 514 514 510 510 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0040961340006"/>
###xml 0 514 0 510 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig6"><label>FIGURE 6.</label><caption><p textid="48"><bold>MacA increases the capacity of MacB to bind erythromycin.</bold> Purified proteins (50 &#956;g of MacA or MacB, or 25 &#956;g of MacA plus 25 &#956;g of MacB) were incubated in the presence of [<italic>N-methyl</italic>-<sup>14</sup>C]erythromycin at concentrations as indicated (1, 5, or 10 &#956;<sc>m</sc>), after which drug binding was measured by rapid filtration. The <italic>bars</italic> represent the erythromycin bound by MacA (<italic>left, black</italic>), MacB (<italic>middle, light gray</italic>), and MacAB (<italic>right, dark gray</italic>). The data indicate that MacA enhances the binding of erythromycin to MacB.</p></caption><graphic xlink:href="zbc0040961340006"/></fig>
FIGURE 6.MacA increases the capacity of MacB to bind erythromycin. Purified proteins (50 mug of MacA or MacB, or 25 mug of MacA plus 25 mug of MacB) were incubated in the presence of [N-methyl-14C]erythromycin at concentrations as indicated (1, 5, or 10 mum), after which drug binding was measured by rapid filtration. The bars represent the erythromycin bound by MacA (left, black), MacB (middle, light gray), and MacAB (right, dark gray). The data indicate that MacA enhances the binding of erythromycin to MacB.
###end p 47
###begin p 48
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MacA increases the capacity of MacB to bind erythromycin.</bold>
###xml 175 183 172 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-methyl</italic>
###xml 184 186 181 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 247 248 243 244 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 314 318 310 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bars</italic>
###xml 361 372 357 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left, black</italic>
###xml 381 399 377 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">middle, light gray</italic>
###xml 413 429 409 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right, dark gray</italic>
MacA increases the capacity of MacB to bind erythromycin. Purified proteins (50 mug of MacA or MacB, or 25 mug of MacA plus 25 mug of MacB) were incubated in the presence of [N-methyl-14C]erythromycin at concentrations as indicated (1, 5, or 10 mum), after which drug binding was measured by rapid filtration. The bars represent the erythromycin bound by MacA (left, black), MacB (middle, light gray), and MacAB (right, dark gray). The data indicate that MacA enhances the binding of erythromycin to MacB.
###end p 48
###begin p 49
###xml 33 35 33 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
In accord with previous studies (24), we could not detect an effect of erythromycin on the kinetics of MacB ATPase either in the absence or presence of MacA (data not shown). Recent studies have established that the ATPase activity of Pdr5 is uncoupled from substrate binding; this basal ATPase activity might be required to constantly cycle the transporter between conformations, so as to maintain the accessibility of the cytosolic substrate-binding site (32). In the case of MacB, its ATPase activity might instead be stimulated by TolC, to reset its conformation following drug transfer to TolC.
###end p 49
###begin p 50
###xml 0 56 0 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacA Increases the Capacity of MacB to Bind Erythromycin</italic>
###xml 177 179 177 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 225 231 225 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
MacA Increases the Capacity of MacB to Bind Erythromycin-Although we could not detect any effect of erythromycin on the ATPase activity of MacB, we could detect the binding of [14C]erythromycin to detergent-solubilized MacB (Fig. 6). Importantly, we found that the MacAB complex bound more erythromycin than MacB alone (which binds considerably more than MacA alone) and that the amount bound increased in a concentration-dependent manner, as would be expected if MacA increased the affinity of MacB for erythromycin. However, because of the insolubility of the antibiotic in aqueous solutions, it was not possible to test a full range of erythromycin concentrations that might saturate MacAB. Consequently, we cannot exclude the possibility of the formation of additional sites within the MacAB complex that are not apparent in either MacB or MacA alone. Our data indicate that MacA not only modulates the ATPase activity of MacB but also enhances its capacity to bind erythromycin (be this due to an increase in affinity of MacB for drugs or the formation of additional drug-binding sites within the MacAB complex).
###end p 50
###begin title 51
DISCUSSION
###end title 51
###begin p 52
###xml 828 835 828 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 870 871 870 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 934 940 934 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 983 989 983 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1096 1097 1096 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1090 1097 1090 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 1281 1282 1281 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">5</xref>
###xml 1287 1288 1287 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">6</xref>
###xml 1354 1374 1354 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Borrelia burgdorferi</italic>
###xml 1444 1446 1444 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 1673 1675 1669 1671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 1785 1793 1781 1789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Borrelia</italic>
###xml 2141 2150 2137 2146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 828 835 <span type="species:ncbi:562">E. coli</span>
###xml 1354 1374 <span type="species:ncbi:139">Borrelia burgdorferi</span>
###xml 2141 2150 <span type="species:ncbi:1280">S. aureus</span>
Gram-negative bacteria possess tripartite pumps that facilitate the extrusion of protein toxins and cytotoxic compounds, such as antibiotics, from the cell. In these tripartite assemblies the IMP is coupled to an OMP by a periplasmic MFP, forming a pump that can translocate molecules across both the inner and outer membranes. Intriguingly, Gram-positive bacteria that lack an outer membrane also possess MFPs, suggesting that they play a role in addition to stabilizing the interaction of the IMP with the OMP. Indeed, we have noted in some of these MFPs a large deletion corresponding to the coiled-coil hairpin that would interact with the OMP (supplemental Fig. 1). To investigate this possibility, we sought to determine the role of MacA, the MFP that couples the IMP MacB, an ATP-driven transporter, with the OMP TolC in E. coli to extrude macrolide antibiotics (3). We established that MacA interacts with both MacB and TolC (Fig. 1) to form a functional tripartite complex (Fig. 2). However, we also found that MacA enhanced the resistance to erythromycin conferred by MacB alone (Fig. 2B), suggesting that it modulated the transport activity of MacB, which is consistent with our data demonstrating that MacA regulates the drug binding and ATPase activity of MacB (Figs. 5 and 6). The role of the MFP BesA in the activity of the BesABC pump in Borrelia burgdorferi, the causative agent of Lyme disease, has recently been highlighted (33). It is quite remarkable that in this system BesA also lacks the alpha-helical hairpin. As such this periplasmic protein is unable to unlock the periplasmic entry site of the OMP, a function that is attributed to the hairpin (11). To compensate, the OMP has evolved to be constitutively leaky. The reason for the retention of BesA in the Borrelia system is most likely associated with its function in the activation of the inner membrane component, in that case an RND transporter. It is conceivable then, that a similar role is also present in the ABC transporters and their associated MFPs, and it could explain the preservation of the hairpin-lacking MFPs in Gram-positive bacteria, such as S. aureus (supplemental Fig. 1).
###end p 52
###begin p 53
###xml 9 16 9 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 568 569 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 562 569 562 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 1209 1211 1209 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 1212 1214 1212 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref39">39</xref>
###xml 2008 2009 2005 2006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">3</xref>
###xml 2014 2015 2011 2012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">4</xref>
###xml 9 16 <span type="species:ncbi:562">E. coli</span>
Although E. coli MacB has an NBD, which incorporates Walker A and B motifs and an ABC signature sequence that are characteristic features of members of the ABC superfamily, it is not a classic ABC transporter. It has a large periplasmic domain, reminiscent of that found in RND transporters, which form trimers in which these domains form substantive sites of contact between the protomers. Consequently, we sought to determine the oligomeric state of MacB and in doing so have developed a novel ES-MS approach to unambiguously establish that MacB forms dimers (Fig. 3C). ES-MS is now widely accepted as a powerful method to determine accurately the stoichiometry of intact protein complexes (34). However membrane proteins, solubilized by detergent or adsorbed in micelles, have remained difficult to analyze under similar MS conditions. The development of strategies to tackle this field is challenging, primarily because the large quantities of detergent suppress the protein signal, whereas the poor solubility of membrane proteins in aqueous buffers often causes the electrospray needle to block. To date only a few MS studies have reported the observation of membrane proteins or their complexes by MS (35-39). Here we report on the use of a miniaturized form of ES with reduced flow rates (nano-ES), and a high collision energy that facilitates the desolvation process and induces dissociation of detergent-proteins clusters, to determine the oligomeric state of an integral homomeric membrane protein. In our protocol we used lower quantities of betaDDM, than have been reported previously, without apparent detrimental effects on the stability of the protein. Under our experimental conditions, we have successfully maintained the noncovalent subunit interactions, such that the oligomeric state of the protein complex could be determined without ambiguity. As would be expected for an ABC transporter in which the NBDs interact, our biophysical studies of MacB indicate that it forms dimers (Figs. 3 and 4 and supplemental Fig. 3). This is an interesting observation because it raises the following question. How does dimeric MacB interact with trimeric TolC and the number of MacA molecules needed to stabilize the tripartite complex? Extension of our AFM studies will be vital for determining the stoichiometry of the interactions to provide an understanding of the assembly of the tripartite complex, which may be difficult to address by other methods, such as crystallization of the complex.
###end p 53
###begin p 54
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref40">40</xref>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref42">42</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref43">43</xref>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref44">44</xref>
###xml 1065 1071 1065 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 1313 1315 1313 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref45">45</xref>
###xml 1623 1625 1623 1625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref46">46</xref>
###xml 1734 1736 1730 1732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 1793 1799 1789 1795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
Our findings and previous studies, which have shown that disruption of the Walker A and B motifs not only inhibits the ATPase activity but also blocks the capacity of MacB to confer macrolide resistance (24), suggest that MacB operates by a similar mechanism to typical ABC transporters. Our understanding of how ABC transporters couple ATP hydrolysis to transport is still rudimentary, but the determination of the crystal structures of several ATPase subunits and complete ABC transporters has suggested conservation of key steps in the molecular mechanism. The binding of ATP to both soluble ATPase subunits (40), solubilized NBDs from ABC transporters (41, 42), and to the NBDs within a complete ABC transporter (43, 44) has been shown to promote dimerization as the ATP is bound at the interface of these nucleotide-binding sites, sandwiched between the Walker A motif of one NBD and the ABC signature motif of the other NBD. Our AFM studies indicated that there is a higher proportion of MacB dimers in the presence of the nonhydrolysable nucleotide AMP-PNP (Fig. 4). In complete ABC transporters, the binding of ATP causes the transporter to adopt a conformation in which the substrate-binding site is outward-facing, because ATP bridges the two NBDs, closing off the inward-facing substrate-binding site (45). Conversely, the release of the hydrolysis products ADP and phosphate is thought to promote an inward-facing conformation, as the structural constraint imposed by binding of the nucleotide is released. Consistent with this proposal, several studies indicate that NBD dimerization cannot be induced by ADP (46), because interactions between the gamma-phosphate of ATP and the signature sequence catalyze these events (47). We found that MacA modulates these processes in MacB (Fig. 5), and so our kinetic data have clear implications in terms of such a mechanism. Most significantly, MacA increases the apparent affinity of MacB for ATP, while decreasing the rate of ATP hydrolysis, so as to promote and stabilize the ATP binding conformation, which we presume to be the conformation in which the antibiotic-binding site is outward-facing. In this manner, MacA would play a direct role in driving antibiotic translocation between MacB and TolC.
###end p 54
###begin p 55
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 475 476 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 476 479 476 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 548 549 548 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 582 586 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 592 598 592 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 605 607 605 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 815 816 815 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 816 819 816 819 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 821 825 821 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 827 830 827 830 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 839 841 839 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 889 890 889 890 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 883 890 883 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g. K<sub>m</sub></italic>
###xml 899 900 899 900 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 973 974 973 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 974 977 974 977 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 979 985 979 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g. k</italic>
###xml 985 988 985 988 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 997 999 997 999 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1041 1042 1041 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1035 1042 1035 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g. K<sub>m</sub></italic>
###xml 1051 1052 1051 1052 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1361 1362 1361 1362 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
During the course of our studies another investigation reported on the effect of MacA on the steady-state ATPase activity of MacB (24). In this study, MacB, solubilized in Triton X-100, appeared to have a specific activity that was an order of magnitude higher than we had found; however, a discontinuous assay was used to determine the ATPase activity, and this could well have been influenced by pooling the time points from both the burst and steady-state phases. Indeed, kcat was marginally slower than the hydrolysis rate determined from the Pi burst phase in our experiments (e.g. 0.17 versus 0.24 s-1). Possibly for similar reasons, this assay did not detect the effect of MacA on MacB solubilized in Triton X-100. However, they did find that MacB reconstituted into liposomes was characterized by a reduced kcat (e.g. kcat = 0.10 s-1) and decreased affinity of MacB for ATP (e.g. Km = 2.30 mm). Co-reconstitution of MacB with MacA had the effect of increasing both kcat (e.g. kcat = 0.78 s-1) and the affinity of MacB for ATP (e.g. Km = 0.38 mm). This behavior is similar to the effect of MacA on the steady-state kinetics of the ATPase activity of solubilized MacB in our study. To know if the reconstituted protein behaves in an identical manner to the solubilized protein would require the reconstitution of sufficient amounts of MacB to define any Pi burst, which is technically demanding. Consequently, although these earlier studies support our conclusion that MacA affects the ATPase activity of MacB, they do not give the detailed insight into the ATPase mechanism provided by our pre-steady-state analyses.
###end p 55
###begin p 56
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">1</xref>
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">2</xref>
###xml 1345 1347 1345 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 1357 1364 1357 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 1560 1562 1560 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref48">48</xref>
###xml 1785 1787 1785 1787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 1909 1911 1909 1911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref50">50</xref>
###xml 1357 1364 <span type="species:ncbi:562">E. coli</span>
Our studies established that conformational changes can be propagated from the periplasmic domain of MacA to the cytoplasmic NBD of MacB (Figs. 1 and 2), and consequently, it is plausible that TolC, by interacting with MacA, can detect the nucleotide state of MacB. The binding of ATP to MacB would stimulate MacA to interact with TolC, inducing the latter to adopt the open state. Because ATP and MacA stabilize in the outward-facing conformation of MacB, drug transfer from MacB to TolC would be facilitated. TolC would then communicate with the NBD of MacB (again, such communication is probably conveyed via MacA) to stimulate ATP hydrolysis, which would be required to reset MacB in the inward-facing conformation. If ATP hydrolysis is controlled by TolC, so that the MacB conformation is only reset after the interaction with TolC and productive transfer of drugs, this would provide an explanation of the apparent insensitivity of the ATPase activity of MacB to drugs. Indeed, without such a feedback control mechanism of drug export, it would appear that drug stimulation of the ATPase activity of MacB would be counter-productive because the MacB conformation could be reset before drug transfer to TolC. There is an analogy in the mechanism of operation of ABC transporters that work in conjunction with a periplasmic binding protein (47). In the E. coli maltose transporter, the binding of ATP to the ATPase subunit MalK induces conformational changes, detected by tryptic digestion, in the periplasmic loops of the membrane subunits MalF and MalG (48), whilst EPR studies revealed that ATP binding, but not ADP binding, caused an increase in affinity between the transporter and the maltose-binding protein (MBP), and "forcing open" the bound MBP to release its substrate (49). The transporter is reset in its original inward-facing conformation by ATP hydrolysis, which is stimulated by the MBP (50). In our model TolC replaces the MBP and, because the open state requires disruption of the second selectivity filter and subsequent twisting of the helices of the TolC channel to keep it fully open, there is a need for the MacA hairpins to stabilize this conformation, which could not be achieved by interaction with MacB alone. Although we have interpreted our findings in terms of an alternating conformation model for MacB, in which the drug-binding sites are inwardly and outwardly exposed, such a model could easily be refined to account for drug binding to a fixed periplasmic site, in analogy to AcrB, with ATP binding and hydrolysis coupled to conformational changes that induce TolC association and dissociation. Clearly the work presented here provides an important framework for further studies that will enable the elucidation of the mechanism underlying the dynamics of assembly of the MacABTolC tripartite pump in the future.
###end p 56
###begin title 57
Supplementary Material
###end title 57
###begin title 58
[Supplemental Data]
###end title 58
###begin p 59
We thank Dr. Martin Moncrieffe (University of Cambridge) for help with the AUC data collection and analysis.
###end p 59
###begin p 60
###xml 339 343 326 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
The abbreviations used are: IMP, inner membrane protein; betaDDM, beta-dodecyl maltoside; MFP, membrane fusion protein; OMP, outer membrane protein; AUC, analytical ultracentrifugation; ES-MS, electrospray-mass spectrometry; AMP-PNP, adenosine 5'-(beta,gamma-imino)triphosphate; S-tag, for proteins fused to the 15-amino acid polypeptide (e.g. Lys-Glu-Thr-Ala-Ala-Ala-Lys-Phe-Glu-Arg-Gln-His-Met-Asp-Ser) derived from RNase A; NBD, nucleotide binding domain; MBP, maltose binding-protein; AFM, atomic force microscopy.
###end p 60

